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Abstract
A macrophage engulfs another cell, or foreign particle, via phagocytosis, an engulfment process crucial not
only to innate and adaptive immunity, but also to the maintenance of homeostasis. Phagocytosis is a receptor-
mediated process that is dependent on Myosin-IIA motors, among other cytoskeletal proteins. Adhesion
processes of both hematopoietic and mesenchymal derived cells can activate Myosin, and increasingly so on
rigid substrates. Macrophage engulfment becomes inefficient if the macrophage also engages `Marker of Self '
CD47 that inhibits Myosin accumulation to the phagocytic synapse. CD47 is a ubiquitously expressed
transmembrane cell surface protein that binds to signal regulatory protein alpha (SIRPA) that is highly
expressed by macrophages. CD47's role in downregulating macrophage phagocytosis was first discovered in
murine erythrocytes (RBCs), where wild-type RBCs are long-lived in circulation, while RBCs derived from a
CD47 knockout mouse are rapidly cleared. More recently CD47 has been found to inhibit clearance of a
variety of viable cell types including stem cells, leukocytes, platelets, and cancers. However, the limitations of
CD47 as a `marker of self ' on apoptotic and experimentally oxidized cells are beginning to be realized, as
CD47 surface expression does not effectively inhibit the phagocytosis of these aged cells.
Furthermore, while it is well known that macrophage-mediated clearance controls the removal of aged RBCs,
that are reported to become rigid, from the bloodstream, the role that rigidification plays in countering CD47
inhibitory signals remains to be clarified. To study the effects of RBC rigidity on the regulation of
phagocytosis by CD47 expression, RBCs were controllably stiffened in different shapes without
compromising CD47-SIRPA interactions. Uptake of antibody-opsonized human-RBC was accelerated, as
expected, by blocking CD47, but was fastest with rigid RBC-Discocytes that mediated maximum levels of
Myosin-IIA accumulation at the phagocytic synapse. Attenuation of the antibody-driven `eat me' signal
partially recovered `Self ' signaling by rigid RBC-Discocytes, and more rounded but rigid RBC-Stomatocytes
also signaled `Self ' more efficiently. These results highlight the biophysical nature of the CD47-SIRPA
inhibitory mechanism that can be overpowered by rigidity and can be rescued by target shape.
Resident tissue macrophages are adept in capturing non-self particles from the extracellular environment,
including HIV-derived lentiviral gene therapy vectors, thus limiting efforts at therapeutic vector delivery.
CD47-SIRPA inhibition has just recently been shown to inhibit in vivo macrophage clearance of nano-sized
synthetic particles that are significantly smaller than previously studied mammalian cells. A novel lentiviral
vector was engineered here to present an oriented human CD47-GFP fusion protein on the vector envelope.
Using Total internal reflection microscopy (TIRFM), atomic force microscopy (AFM), and immunoblotting,
we have demonstrated that engineered lentivectors display the CD47-GFP protein. In vivo results show that
lentiviral vector display of CD47 increases circulation of the vector in the bloodstream, and reduces off-target
transgene expression in splenic and liver macrophages. Use of this CD47-displaying lentiviral vector, further
shows increased delivery to solid tumors. CD47 on the surface of lentiviral gene therapy vectors was found to
attenuate off-target macrophage uptake of the vector, and thereby increase therapeutic efficiency.
The results here examine the boundaries of CD47's role as a `marker of self '; CD47 inhibition is diminished
on the surface of rigid self-cells, while an enveloped virus shows the potential to masquerade as self by taking
its envelope from a cell with sufficient CD47. The observed role of red cell shape and rigidity in CD47s ability
This dissertation is available at ScholarlyCommons: http://repository.upenn.edu/edissertations/1451
to signal self highlights the biophysical aspect of phagocytosis with implications for CD47 inhibition of
clearance of aged, diseased, and cancerous cells that differ from viable cells in their physical properties. Study
of the novel CD47-lenti reveals the first evidence of CD47 being able to limit macrophage engulfment of a
non-mammalian physiological entity, as current studies have as of yet been limited to mammalian cells and
synthetic particles. This finding may have potential application in the understanding of disease progression
and vaccine development for enveloped viruses such as HIV-1.
Degree Type
Dissertation
Degree Name
Doctor of Philosophy (PhD)
Graduate Group
Chemical and Biomolecular Engineering
First Advisor
Dennis E. Discher
Keywords
CD47, HIV-1, lentiviral gene therapy, mechanosensitive, phagocytosis, red blood cell
Subject Categories
Biophysics | Chemical Engineering | Virology
This dissertation is available at ScholarlyCommons: http://repository.upenn.edu/edissertations/1451
	  
	  
INHIBITING PHAGOCYTOSIS WITH CD47:  FROM THE EFFECTS OF RED CELL 
RIGIDITY AND SHAPE TO DISPLAY ON LENTIVIRUS – IMPLICATIONS FOR AGING 
AND GENE THERAPY  
 
Nisha G. Sosale 
 
A DISSERTATION 
in 
Chemical and Biomolecular Engineering 
 
Presented to the Faculties of the University of Pennsylvania 
in 
Partial Fulfillment of the Requirements for the 
Degree of Doctor of Philosophy 
2014 
Supervisor of Dissertation      
______________      
Dennis E. Discher          
Professor of Chemical and Biomolecular Engineering 
 
Graduate Group Chairperson 
_________________ 
Raymond J. Gorte, Professor of Chemical and Biomolecular Engineering 
 
Dissertation Committee  
Dennis E. Discher, Professor of Chemical and Biomolecular Engineering 
Matthew J. Lazzara, Assistant Professor of Chemical and Biomolecular Engineering 
John C. Crocker, Professor of Chemical and Biomolecular Engineering 
Carolina B. Lopez, Assistant Professor of Pathobiology  
  
 
 
 
INHIBITING PHAGOCYTOSIS WITH CD47:  FROM THE EFFECTS OF RED CELL 
RIGIDITY AND SHAPE TO DISPLAY ON LENTIVIRUS – IMPLICATIONS FOR AGING 
AND GENE THERAPY  
COPYRIGHT 
2014 
Nisha G. Sosale 
This work is licensed under the  
Creative Commons Attribution- 
NonCommercial-ShareAlike 3.0 
License 
 
To view a copy of this license, visit 
http://creativecommons.org/licenses/by-ny-sa/2.0/
iii	  
	  
ACKNOWLEDGMENTS	  
 
 
I would like to thank my supervisor, Prof. Dennis E. Discher, for his guidance throughout my 
training, as well as my thesis committee, Prof. Matthew Lazarra, Prof. Carolina Lopez, and Prof. 
John Crocker. I greatly appreciate the advice given by Dr. Rumiana Dimova, Dr. Irena I. 
Ivanovska, Dr. Philip Z. Zoltick, and Prof. Reinhardt Lipowsky. I also thank my parents Nagendra 
and Nagamani, my sister Navya, my best friend Kristen Carson, and my fiancé Warren Anderson 
for their much-appreciated support. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iv	  
	  
ABSTRACT 
 
INHIBITING PHAGOCYTOSIS WITH CD47:   
FROM THE EFFECTS OF RED CELL RIGIDITY AND SHAPE              
TO DISPLAY ON LENTIVIRUS – 
 IMPLICATIONS FOR AGING AND GENE THERAPY 
Nisha G. Sosale 
Dennis E. Discher 
 
A macrophage engulfs another cell, or foreign particle, via phagocytosis, an engulfment process 
crucial not only to innate and adaptive immunity, but also to the maintenance of homeostasis. 
Phagocytosis is a receptor-mediated process that is dependent on Myosin-IIA motors, among 
other cytoskeletal proteins. Adhesion processes of both hematopoietic and mesenchymal derived 
cells can activate Myosin, and increasingly so on rigid substrates. Macrophage engulfment 
becomes inefficient if the macrophage also engages ‘Marker of Self’ CD47 that inhibits Myosin 
accumulation to the phagocytic synapse. CD47 is a ubiquitously expressed transmembrane cell 
surface protein that binds to signal regulatory protein alpha (SIRPA) that is highly expressed by 
macrophages.  CD47’s role in downregulating macrophage phagocytosis was first discovered in 
murine erythrocytes (RBCs), where wild-type RBCs are long-lived in circulation, while RBCs 
derived from a CD47 knockout mouse are rapidly cleared. More recently CD47 has been found to 
inhibit clearance of a variety of viable cell types including stem cells, leukocytes, platelets, and 
cancers. However, the limitations of CD47 as a ‘marker of self’ on apoptotic and experimentally 
oxidized cells are beginning to be realized, as CD47 surface expression does not effectively 
inhibit the phagocytosis of these aged cells.  
Furthermore, while it is well known that macrophage-mediated clearance controls the removal of 
aged RBCs, that are reported to become rigid, from the bloodstream, the role that rigidification 
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plays in countering CD47 inhibitory signals remains to be clarified. To study the effects of RBC 
rigidity on the regulation of phagocytosis by CD47 expression, RBCs were controllably stiffened in 
different shapes without compromising CD47-SIRPA interactions. Uptake of antibody-opsonized 
human-RBC was accelerated, as expected, by blocking CD47, but was fastest with rigid RBC-
Discocytes that mediated maximum levels of Myosin-IIA accumulation at the phagocytic synapse. 
Attenuation of the antibody-driven ‘eat me’ signal partially recovered ‘Self’ signaling by rigid RBC-
Discocytes, and more rounded but rigid RBC-Stomatocytes also signaled ‘Self’ more efficiently. 
These results highlight the biophysical nature of the CD47-SIRPA inhibitory mechanism that can 
be overpowered by rigidity and can be rescued by target shape.   
Resident tissue macrophages are adept in capturing non-self particles from the extracellular 
environment, including HIV-derived lentiviral gene therapy vectors, thus limiting efforts at 
therapeutic vector delivery. CD47-SIRPA inhibition has just recently been shown to inhibit in vivo 
macrophage clearance of nano-sized synthetic particles that are significantly smaller than 
previously studied mammalian cells. A novel lentiviral vector was engineered here to present an 
oriented human CD47-GFP fusion protein on the vector envelope. Using Total internal reflection 
microscopy (TIRFM), atomic force microscopy (AFM), and immunoblotting, we have 
demonstrated that engineered lentivectors display the CD47-GFP protein. In vivo results show 
that lentiviral vector display of CD47 increases circulation of the vector in the bloodstream, and 
reduces off-target transgene expression in splenic and liver macrophages. Use of this CD47-
displaying lentiviral vector, further shows increased delivery to solid tumors. CD47 on the surface 
of lentiviral gene therapy vectors was found to attenuate off-target macrophage uptake of the 
vector, and thereby increase therapeutic efficiency.  
The results here examine the boundaries of CD47’s role as a ‘marker of self’; CD47 inhibition is 
diminished on the surface of rigid self-cells, while an enveloped virus shows the potential to 
masquerade as self by taking its envelope from a cell with sufficient CD47. The observed role of 
red cell shape and rigidity in CD47s ability to signal self highlights the biophysical aspect of 
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phagocytosis with implications for CD47 inhibition of clearance of aged, diseased, and cancerous 
cells that differ from viable cells in their physical properties. Study of the novel CD47-lenti reveals 
the first evidence of CD47 being able to limit macrophage engulfment of a non-mammalian 
physiological entity, as current studies have as of yet been limited to mammalian cells and 
synthetic particles. This finding may have potential application in the understanding of disease 
progression and vaccine development for enveloped viruses such as HIV-1. 
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CHAPTER 1: INTRODUCTION 
	  
(0) Significance & Motivation 
	  
More than 100 years ago Elie Metchnikov, while observing starfish larvae, noted that where a 
rose-thorn that had pierced the echinoderms translucent outer layer, the puncture was 
surrounded by ameboid-like cells he referred to as  ‘macrophage’, which in greek translates to 
‘big eater’  (Nathan 2008). These seminal studies marked the discovery of what is referred to 
today as the innate immune system and is made up in part by macrophages.  
Macrophages carry out a diverse set of roles, key to which is phagocytosis, a cellular uptake or 
‘eating’ process that allows for the clearance of foreign microbes, wound repair, and the bridging 
of innate and adaptive immune response by presenting engulfed antigens to lymphocytes 
(Janeway 2005, Lawrence 2011, Murray 2011). Resident macrophages are present in most 
tissues (Davies 2013). Understanding the mechanism and regulation of macrophage function is 
crucial to developing treatments towards a plethora pathological conditions caused by 
dysregulation of macrophage physiology, including Chrohn’s disease (Baba 2013), Alzheimer’s 
disease (Gate 2010), Asthma (Balhara 2012), and Cancer (Pollard 2009). Increased 
understanding is also crucial to the optimization of targeted therapeutics that must evade the 
immune system in order to reach target tissues (Scherphof 2006).  
In the last two decades much has been discovered about the molecular mechanisms behind 
phagocytosis, a cytoskeleton-driven uptake process (May 2001, Swanson 2008, Flanagan 2012).  
Resident macrophages are adept at recognizing foreign pathogens through ‘non-self’ proteins on 
the pathogen surface (Loegering 1989), but also through the absence of ‘self’ proteins that 
include CD47. Cell-surface protein CD47 has been shown to inhibit phagocytosis of RBCs 
(Oldenborg 2000). SIRPA is an immunoinhibitory surface protein (Ravetch 2001), and ligand for 
CD47 (Jiang 1999). Signaling downstream of macrophage SIRPA affects the balance of kinase- 
and phosphatase-mediated phosphorylation and regulation of proteins involved in cytoskeletal 
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mobilization in phagocytosis. These signals can respectively activate and deactivate the 
macrophage cytoskeleton during phagocytosis (Tsai 2008).  
CD47 inhibition has been best characterized in its inhibition of FcγR mediated phagocytosis 
(Oldenborg 2000), and, FcγR is the most studied phagocytic uptake mechanism (Flannagan 
2012). CD47 inhibits phagocytosis of a range of viable cell types including erythrocytes 
(Oldenborg 2001, Tsai 2008), leukocytes (Gardai 2005), stem cells (Blazar 2001), and some 
cancers (Weiskopf 2013). While CD47 makes phagocytosis of viable cells inefficient, it remains to 
be clarified how cellular aging allows pro-phagocytic signals to dominate CD47 inhibition and thus 
the efficient clearance of aged cells. Details of the mechanism of uptake of aged or apoptotic cells 
continue to be elucidated, and if and how CD47 may regulate this uptake is of key importance to 
understanding both homeostasis and disease (Tada 2003, Gardai 2005, Olsson 2008). Here we 
examine how rigidity of a phagocytic target affects CD47 inhibition of macrophage 
phagocytosis. 
For more than 3 decades erythrocytes have served as model systems for understanding 
macrophage phagocytosis (Flannagan 2012), including the seminal studies that identified CD47 
as a marker of self (Oldenborg 2000). The finely tuned production and turnover of erythrocytes, 
that is in part dependent on macrophage phagocytosis, is an essential physiological process.  
Efficient clearance of apoptotic cells is key to tissue homeostasis and to minimizing lysis-induced 
inflammation (Erwig 2008). Thus, erythrocytes are a logical and relevant model for understanding 
CD47’s role in the clearance of aged and cells that become rigidified with time in circulation 
(Chasis 1986). Aged, apoptotic and diseased cells differ from viable cells in many ways 
(DeCathelineau 2003) including cell rigidity and shape (Mohandas 2008). As cells age they 
become oxidized by prolonged exposure to reactive oxygen species, and this is especially 
relevant to erythrocytes that are responsible for oxygen transport between the lungs and tissues 
(Barelli 2008). This oxidation can trigger chemical changes (Lang 2014) including production of 
physiological aldehydes and protein cross-linking (Jain 1983) that can ultimately lead to 
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rigidification of the aged cell. The study of CD47 inhibition on rigidified erythrocytes may also be 
relevant to diseased cells that become rigidified, such as sickle cell erythrocytes (Itoh 2002) and 
chemotherapy-treated cancers (Lam 2007).   
Studies of the CD47 inhibition mechanism have been thus far limited to mammalian cells and 
synthetic particles. The mechanism of phagocytosis evolved before the rise of multicellular 
organisms, while CD47 is restricted to higher organisms, namely mammals. This suggests that 
the CD47-SIRPA inhibitory signaling mechanism arose with multicellular organisms whose 
immune systems have a dual charge—first, protect ‘self’ and second, attack ‘non-self’. The work 
here extends our knowledge of the CD47 mechanism into the role of CD47 in macrophage 
clearance of lentiviruses. An enveloped poxvirus (Family, Poxviridae, Genus Leporipoxvirus) is 
reported to encode a CD47 homologue (Cameron 2005), and enhances the pathogenicity of the 
virus. This initial evidence led to the hypothesis driving this study: CD47 display by enveloped 
lentiviral vectors may inhibit their uptake by macrophage and provide the potential for 
improving lentiviral vector-mediated gene therapy.  
There have been recent successful lentiviral vector clinical trials in the treatment of genetic 
disorders including as thalassemia and Wiskott Aldrich syndrome, that are both caused by a 
missing or defective gene (Aiuti 2013). However, gene-therapy treatments have been limited to 
ex-vivo lentiviral treatments of stem cells, followed by transplantation. This is in part because in-
vivo delivery is currently challenged by efficient macrophage clearance of the therapeutic vector 
thus limiting delivery to target cells (Follenzi 2002, Van Til 2004). Enveloped HIV viruses (Family 
Retroviridae, Genus Lentivirus) derive their viral envelope from the lipid bilayer of the host 
mammalian cell (Desport 2010).  In this work, controlled studies of a novel CD47-displaying 
lentiviral vector allowed for increased understanding of how viral-CD47 display affects 
macrophage uptake, and how this impacts in vivo clearance and gene delivery to a target cell. 
This dissertation work addresses several questions regarding the regulation of 
phagocytosis by CD47 in two specific clinically relevant contexts: (1) rigidified 
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erythrocytes and (2) lentiviral vector gene therapy. The work here is motivated by the goals of 
furthering the basic insight into CD47-inhibition of macrophage phagocytosis, and gaining 
understanding of how physical parameters such as rigidity and shape affect the immuno-inhibitory 
mechanism of CD47.  Here we aim to extend understanding of the CD47 mechanism in the 
context of rigidified erythrocytes and lentiviral gene therapy vectors. The following introduction 
provides background on (1) Macrophage Phagocytosis, (2) CD47-SIRPA Inhibition of 
Phagocytosis, (3) macrophage clearance of aged erythrocytes, and  (4) lentiviral vector mediated 
gene therapy.   
	  
(1) Macrophage Phagocytosis 
	  
The earliest models define innate immunity as the rapid response of the immune system based 
on the relatively non-specific defense against non-self versus self-entities (Janeway 2005). A 
more recent model of immunity considers instead that the immune system distinguishes between 
entities that do damage versus those that do not (Matzinger 2002). This model may be relevant to 
the systems studied here where aged self-RBCs need to be efficiently cleared to prevent 
premature hemolysis and release of potentially inflammatory intracellular components (Erwig 
2008).  The model may also be more relevant to replication incompetent non-self lentiviral vectors 
that can potentially be life saving. Macrophages can recognize targets via bound molecules, 
including immunoglobulins, which can become deposited, and thus opsonized, both red blood 
cells (Franco 2013) and lentiviral vectors (DePolo 2000). Following opsonin recognition, a 
macrophage can engulf the recognized particle via a cellular uptake mechanism known as 
phagocytosis. Macrophages can distinguish self through SIRPA binding of CD47. The role of 
CD47-SIRPA signaling in regulating macrophage phagocytosis is the focus of this work. 
Specifically in the regulation of Fcγ receptor mediated macrophage phagocytosis.  
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FcgR signaling leads to the activation of macrophage cytoskeleton and phagocytosis. Some of 
the proteins involved in FcgR phagocytosis include the following:  tyrosine kinases, adaptor 
proteins, lipid modification enzymes, Guanine nucleotide exchange factors, small GTPases, 
nucleation promotion factors, the Actin Nucleation Complex: Arp2/3. Myosin motors including 
Myosin II also become activated. Engagement of the Fcγ Receptor by IgG leads to clustering and 
activation of the receptors. The cytoplasmic domain of FcγR contains an ITAM (immunoreceptor 
tyrosine-based activating motif), a tandem YxxI/L motif. Following this clustering event, Src family 
kinases, known to be integral in early phagocytic events, phosphorylate ITAM tyrosine residues. 
Src family kinases involved include Hck, Lyn, Fgr (Ghazizadeh 1999). Src family kinase, Syk is 
the first kinase to become activated by FcgR ITAM. Early phagocytic events appear to be 
independent of Syk, but completion of phagocytosis requires Syk, as Syk-/- mice are deficient in 
completion. Syk phosphorylation leads to recruitment of adaptor proteins involved in signaling: 
LAT, Grb2, Gab2, & Crk III. Lipids are critical to phagocytic signaling where changes in lipid 
composition are restricted to the phagocytic cup.  
Macrophage pseudopods surround the target during phagocytosis (Swanson 1999). These 
pseudopods consist of a meshwork of filamentous actin polymers. Small GTPases are key to 
actin dynamics. Actin filaments are dynamic polymers formed by treadmilling, and actin-polymer 
formation requires actin nucleating complex Arp2/3.  Arp2/3 is activated by both Nucleation 
promoting factors, WAVE and WASP, GTPase Cdc42, and phospholipids.  In addition to 
filamentous actin filaments, myosin motors are also reported to be key to phagocytic uptake. 
Myosin II is recruited to early phagosomes where it is expected to play a role in pseudopod 
adhesion and closure (Vicente-Manzanares 2004). Phagocytic engulfment is proportional to 
myosin II activation, and this highlights the role they play in engulfment.  
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(2) CD47-SIRPA Inhibition of Phagocytosis 
The CD47 protein consists of a single immunoglobulin superfamily domain, a hydrophobic 
transmembrane penta-spanning domain, and a cytoplasmic tail with several splice variants 
(Brown 2001, Matozaki 2008).  CD47 ligands include integrins, thrombospondin-1, and SIRPA 
(Brown 2001). CD47 interactions with SIRPA are the focus of this work. SIRPA is mainly 
expressed in neurons, dendritic cells, and macrophages (Matozaki 2008). SIRPA may also be 
found on other cell types including neurons and epithelial cells. The extracellular portion of SIRPA 
consists of three Ig-domains that gives this receptor-ligand pair a unique ‘3+1’ topology. However 
this can be expected to span a similar distance as canonical ‘2+2’ Ig-domain synapse protein 
pairs (Greenberg 1994), such as that between phagocytic Fcγ receptors for immunoglobulin. 
CD47 is ubiquitously expressed on mammalian cells, and erythrocytes display 25,000 molecules 
per cell (Mouro-Chanteloup 2003). The major fraction of CD47 is immobile within the erythrocyte 
ankyrin membrane protein-complex (Dahl 2003), and is linked to the complex via an interaction 
with protein 4.2 (Dahl 2004). Fluorescence imaging micro-deformation (FIMD) studies indicate the 
minor fraction of CD47 is freely diffusible within the lipid bilayer (Dahl 2003). CD47 has been 
shown to be species specific (Subramanian 2006), and studies with human cells have been few 
thus far. 
 
CD47 binding promotes the phosphorylation of tyrosine residues of SIRPA’s cytoplasmic 
immunoreceptor tyrosine-based inhibitory motif  (ITIM)  (Okazawa 2005, Matozaki 2008). SIRPA 
is among a family of ITIM-containing immune inhibitory receptors, that also includes, the B-cell 
inhibitory receptor PIR-B (Ravetch 2001). These serve as an important balance to signals 
generated from activating receptors, such as some classes FcγR receptors (Figure 1). The 
phosphorylated tyrosine’s of SIRPA bind to, and appear to act as a substrate for, the Src 
homology 2 (SH2) domain-containing protein tyrosine phosphatases, SHP-1 and SHP-2, thereby 
activating the phosphatases (Kharitonenkov 1997). SHP-1 is reported to be predominantly 
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expressed in hematopoietic cells, and tends to be an inhibitory phosphatase, while SHP-2 is 
expressed in most cell types. Activated SHP-1 can deactivate Myosin-II (Baba 2003). 
Macrophage interaction with CD47 displaying erythrocytes leads to decreased phosphorylation of 
a tyrosine residue in the myosin-II heavy chain, along with both reduced myosin-II accumulation 
at the phagocytic synapse and reduced phagocytic engulfment (Tsai 2008). 
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Figure 1. CD47-SIRPA Inhibition of Macrophage. CD47 binds to macrophage receptor, SIRPA, 
which can lead to the phosphorylation of the ITIM motif (Immunoreceptor Tyrosine-based 
Inhibitory Motif) located on SIRPA’s cytoplasmic domain. The phosphorylated tyrosine’s of 
SIRPA’s ITIM are reported to act as a substrate for, the Src homology 2 (SH2)	  domain-containing 
protein tyrosine phosphatase, SHP-1 (Kharitonenkov 1997). In parallel, FcγR receptors may bind 
to IgG that can specifically bind to the surface of a phagocytic target, and this leads to 
phosphorylation of the ITAM motif (Immunoreceptor Tyrosine-based Activation Motif) on the 
cytoplasmic region found on some classes of FcγR receptors. Cytoskeletal proteins, including 
myosin-II, become activated following FcγR ITAM phosphorylation. While, SHP-1 is reported to 
deactivate several proteins involved in phagocytic uptake, including myosin-II (Baba 2003). Thus, 
CD47-SIRPa signaling can inhibit myosin-driven FcγR mediated uptake.	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The key in vivo evidence thus far for a marker-of-self role for CD47-SIRPA interactions comes 
from CD47-knockout mice. When red cells from these mice are injected into the circulation of 
control mice, the deficient cells are cleared within hours by macrophages in the spleen, whereas 
normal red cells circulate for weeks (Oldenborg 2000).  Additional in vitro studies with both mouse 
and human red cells have largely confirmed that the “eat me not” signal can counter “eat me” 
signals on erythrocytes (Oldenborg 2001, Tsai 2008). In vitro studies of microparticles have 
shown that SIRPA activation increases to saturation with CD47 density indicating CD47’s real but 
limited ability to inhibit phagocytosis (Rodriguez 2013). In addition to erythrocytes, CD47 has 
been found to inhibit the uptake of leukocytes (Gardai 2005), stem cells (Blazar 2001), platelets 
(Olsson 2005), and cancer cells (Jaiswal 2009). However, CD47 inhibition of the uptake of 
apoptotic leukocytes (Gardai 2005) is limited. In apoptotic leukocytes, CD47 has been reported to 
localize to membrane patches distinct from those containing pro-phagocytic signals. How CD47 
signaling may be affected by cellular aging is discussed in more detail in the next section.  
	  
(3) Macrophage Clearance of Aged Erythrocytes  
	  
Erythrocytes (RBCs, red cells) are enucleated cells that transport oxygen throughout the body  
(Bruce 2003). With up to 1010 red cells being produced per hour during hematopoiesis, the 
efficient removal of aged red cells is clearly an essential process. As erythrocytes pass through 
the lungs more than 1x105 times in their 120-day life span, they can accumulate oxidative 
damage (Lang 2014). Blood storage is also thought to cause oxidative stress similar to that which 
occurs in vivo (D’Amici 2007, Barelli 2008). Stored blood is generally cleared faster than normal 
(Deplaine 2011), and this contributes to clinical problems such as transfusion related acute injury 
(Hod 2010). As RBCs senesce, aldehydes can be produced, and experimental aldehyde 
rigidification increases RBC clearance from the circulation (Jain 1983). Aldehydes react primarily 
with amines in Lysine residues, to covalently cross-link proteins. Here, glutaraldehyde was used 
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to controllably cross-link and rigidify red cells, to understand the effect of cross-linking and 
rigidification on CD47 inhibition of macrophage phagocytosis. 
Loss of CD47’s protective role has long been hypothesized to impact clearance of senescent 
cells (Oldenborg 2000).  Some reports indicate that during red cell storage, CD47 is lost from the 
cell surface, potentially via the release of protein containing membrane vesicles (Annis 2002, 
Kamel 2010, Stewart 2005, Fossati-Jimack 2002, Khandelwal 2007). However, other studies find 
no such loss in CD47 display with storage (Sparrow 2006, Holovati 2008). So, physical loss of 
CD47 does not seem to fully explain enhanced clearance of aged red cells. Oxidized and aged 
RBCs may differ from healthy RBCs in a number of ways besides decreased CD47 display. 
These can include CD47 clustering, increased IgG deposition, and changes in biophysical 
properties including cell rigidity and shape (Gardai 2005, Franco 2013, Mohandas 2008). The 
latter are the focus of this work as aged RBCs are cleared from circulation by two mechanisms 
that are both affected by the physical properties of the aged RBCs. These are physical exclusion 
from the vasculature and macrophage phagocytosis.  
Healthy erythrocytes are reported to be readily deformable under applied shear stresses of that 
are similar in magnitude to those experienced by red cells in the circulation (Jain 1983). As they 
age, erythrocytes show decreased deformability relative to young cells. Deformability of red cells 
is crucial to their circulation through the microvasculature that can become as small as 3 µm in 
diameter (Deplaine 2011, Tsai 2012).  Deformable discoid red cells are able to deform as they 
travel through small channels, and at times take on a parachute-like morphology (Skalak 1969). 
Aged red cells, that are more rigid than their younger counterparts, become trapped in splenic 
slits of the sinusoids to a greater extent than non-rigid cells (MacDonald 1987, Buffet 2011, 
Mebius 2008).  
Macrophages are reported to contribute to the in vivo clearance of erythrocytes (Kay 1975, 
Oldenborg 2000). FcγR mediated phagocytosis is driven by the accumulation of myosin-II motors 
to a phagocytic synapse between a macrophage and a target cell. The motors drive actin 
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pseudopods to engulf the phagocytic target (Vincente Manzanares 2004). Work from our lab has 
shown that CD47 inhibits accumulation of myosin-II to the phagocytic synapse (Tsai 2008), While 
substrate rigidity drives cell spreading with assembly of stress fibers and polarization of non-
muscle myosin-II for many cell types (Lo 2004, Engler 2006 Raab 2012, Oakes 2009, Shin 2014). 
Macrophages are mechanosensitive in adhesion and phagocytosis, and exhibit increased 
adhesion and cell spreading on stiffer substrates (Fereol 2006, Patel 2012, Blakney 2012). 
Macrophages have been shown to preferentially engulf rigid polyacrylamide beads, as compared 
to softer beads (Beningo 2002).  Further, in vivo studies of controllably stiffened hydrogel 
particles, similar in morphology to RBC Discocytes, show that stiff gel particles are cleared more 
rapidly than soft particles, becoming entrapped in the lungs, among other organs. However, the 
aforementioned studies focus on non-physiological substrates, and thus the relevance of these 
findings to phagocytic uptake of cells that display CD47, is yet unknown (Merkel 2011). 
Deformability also affects the shape of the target as perceived by the engulfing macrophage. For 
example fresh deformable erythrocytes take on a quasi-spherical shape during initial adhesion 
with macrophage. In contrast rigid RBCs retain the discoid shape. Target shape has been 
reported to be key to clearance. Spherical polystyrene particles are engulfed more readily than 
elliptical and cylindrical particles (Champion 2006). High resolution EM imaging shows that actin 
pseupods adhere more uniformly at the synapse with spherical particles as compared to 
synapses with ellipsoids, in a manner dependent on the orientation of the non spherical particles. 
This may contribute to enhanced engulfment of spherical particles, but whether this phenomenon 
is relevant to CD47 inhibition of biological cells, specifically RBC Discocytes, is examined in this 
work. 
Red cells pass through the lungs more than 105  times during their lifetime, causing them to be 
sensitive to oxidation that can lead to exposure to physiological aldehydes and subsequently 
cross-linking that increases cell rigidity. Rigidity may contribute to two mechanisms of clearance 
(1) physical entrapment in the vasculature and (2) macrophage phagocytosis (Figure 2). This 
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work focuses on the latter.  Target rigidity is expected to activate macrophage Myosin-II, as 
observed in macrophage adhesion on rigid substrates. This counters CD47 inhibition of myosin II 
so that the inhibitory capacity of CD47-SIRPA to inhibit phagocytosis of rigidified cells is limited.  
This work thus aims to further clarify effect of target stiffness and shape on CD47 inhibition of 
phagocytosis.  
	  
	  
	  	  
Figure 2.  Mechanisms of rigidification and clearance of red blood cells. Red blood cells are 
pumped by the heart and passed through the lungs on the order of 1 x 105 times within their 120 
day life-span. In doing so they become exposed to reactive oxygen species and aldehydes that 
can lead to protein cross-linking and thus rigidification of the aged cells. Aged cells can be 
cleared by two mechanisms throughout the body. These mechanisms are illustrated for example 
in a splenic sinusoid, where blood is filtered. (1) The rigidified aged cells can become physically 
entrapped within splenic slits as well. (2) They can also be cleared more readily by macrophage, 
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as macrophage phagocytosis is reported to be mechanosensitive, with more rigid particles being 
more readily engulfed (Beningo 2002). 
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(4) Lentiviral vector Mediated Gene Therapy 
	  
The therapeutic potential of Lentiviral Vectors (Lentis) is convincingly evidenced by the successful 
developments in ex vivo treatments of stem cells (Worsham 2006, Lee 2009) and recent clinical 
trials  (Cartier 2009, Aiuti 2013). Lentis offer an advantage over carriers such as liposomes and 
other viral vectors in that they are capable of stably integrating genetic material in a wide range of 
cell types (Naldini 1996). Lentiviruses, unlike other retroviruses, can transduce non-replicating 
cells where the chromosomal DNA is not readily accessible (Naldini 1996). Lentiviral vectors are 
advantageous over Adenoviral vectors that have been found be very immunogenic, and now are 
mainly used in the context of vaccines where an adaptive immune response is the desired 
outcome (Varnavski 2002). The lentivector can carry a relatively large transgene and have been 
reported to have no upper bound in transgene size, with inserts ~18kb being packaged (Kumar 
2001).  There is no report of cellular transformation as a result of lentiviral transduction, which is 
an advantage over other retroviral vectors such as Murine Leukemia vectors (Hacein-Bey Abina 
2003). 
The recent clinical trials  (Cartier 2009, Aiuti 2013) were limited to ex vivo lentiviral treatments of 
hematopoietic stem cells followed by autologous transplantation. This is, in part, because 
lentiviral vectors are primarily cleared by macrophages in studies of in vivo delivery. 
Biodistribution analyses show that the majority of the delivered transgene can be found in the 
spleen, liver, and bone marrow (Pan 2002, Follenzi 2002). Furthermore, Immunohistochemical 
analyses of the murine liver reveal that the majority of transgene expression is found within 
Kupffer cells, the spider-like resident macrophage of the liver (van Til 2004). Thus the in vivo 
clearance of Lentis is in part mediated by resident macrophage, and likely involves recognition of 
IgG bound to the LV surface. VSV-G pseudotyped lentiviral vectors cab become neutralized by 
IgGs found in naïve serum (DePolo 2000). Fetal bovine serum that is used in lentiviral vector 
production can also contain anti-viral IgGs (Offit 1984). Immunoblotting analyses of serum from 
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pre-injected and vector-injected mice suggest that mice have pre-existing anti-vector antibodies  
(Baeklandt 2003). 
Current methods of enhancing delivery of lentiviral vectors have focused on engineering the 
surface of the vector to display novel of envelope proteins, known to bind a specific target cell 
with relatively high affinity, in order to preferentially enhance gene transfer within that target cell 
(Bischof 2010, Frecha 2008, Di Nunzio 2007). This technique takes advantage of the fact that 
lentiviruses are enveloped viruses that self assemble beneath the cellular surface, taking a piece 
of the lipid bilayer as the viral envelope as it buds from the cell in a cytoskeleton driven manner 
(Gladniikoff 2009). Therefore proteins displayed on the cell surface during lentiviral transfection 
have the potential to also become displayed on the lentiviral vector surface.  
Target cell specific promoters have also been engineered to enhance gene expression within 
target cell transduction (Follenzi 2004, Brown 2007). Additionally small inducer molecules have 
been engineered to induce regulated transgene transcription, whereby the therapeutic gene is 
only transcribed upon the administration of the small molecule (Vogel 2008). These current 
approaches enhance entry to target cells, but do not directly reduce uptake or gene expression in 
phagocytes. Reducing LV uptake by macrophage cells via CD47 display is optimal in that it 
reduces the large loss of vector to an off-target macrophage. The increased amount of LV 
available in circulation enhances the chance of the LV to reach a target cell type. 
Lentiviruses, including HIV-1, are nanoparticles, with diameters that are reported to range 
between 90 and 260 nanometers (Fuller 1997, Dorfman 1994, Reicin 1996, Nakai 1996). The 
lentivirus assembles beneath the cell membrane inducing membrane curvature, leading to the 
formation of a bud. The budding process is complete when the quasi-spherical virion buds from 
the cell, enveloped in the plasma membrane and associated integral membrane proteins (Barerra 
2008). The curvature may in part be induced by capsid protein (Lanman 2004). HIV-1 contains an 
inner core composed  mainly of three key structural proteins matrix, nucleocapsid, capsid (p24), 
with the latter assembling as hexamers and pentamers into a ‘fullerene cone’ lattice (Zhao 2013). 
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The nucleocapsid is associated with the viral RNA while matrix is reported to play a number of 
roles including linking the viral envelope with the capsid (Bukrinskaya 2007).  
The lentiviral vector is an engineered form of HIV. The genes encoding the structural elements, 
envelope material, and the therapeutic transgene have been engineered to three distinct 
plasmids (Dull 1998). Following the 5’ long terminal repeat region of the lentivector’s therapeutic 
gene sequence there is a highly structured RNA sequence, known as the packaging signal (Ψ) 
that has a strong affinity for the viral nucleocapsid protein (Russel 2003), and thus is the only 
genetic material that becomes encapsidated. This renders the viral vector unable to replicate 
since the genes for structural proteins, are not encapsidated. VSV-G, the vesicular stomatitis 
virus envelope glycoprotein, is commonly used lentiviral vector envelope protein (Naldini 
1996).VSV-G mediates efficient gene transfer in a wide range of cell types (Farley 2007) and 
remains functional upon exposure to the force imposed by ultracentrifugation-based purification 
and concentration processes (Reiser 2000).  Reverse transcriptase and integrase, virally 
encoded enzymes, are encapsidated within the vector and mediate reverse transcription and 
integration of the transgene into the host genome. The lentiviral vector is thus an efficient non-
replicating gene transfer vector. 
Synthetic particles that were engineered to display a recombinant CD47 protein show prolonged 
in vivo circulation and enhanced tumor delivery (Rodriguez 2013).  While phagocytosis is typically 
defined to be limited to the engulfment of micron-sized particles, studies of nanobeads and 
viruses show that their uptake is enhanced by IgG interactions (Rodriguez 2013, Takeda 1990). 
Further the reduced uptake of CD47-nanoparticles appears to be dependent on the SIRPA 
inhibition pathway, as uptake is increased to levels compared to a control nano-bead by both 
SIRPA blocking (anti-mSIRPA) and a pharmacological SHP-1 inhibitor (NCS-87877). The 
hypothesis driving this work is that LVs can be engineered to display CD47 on their surface, and 
this CD47 display will reduce macrophage uptake thus enhancing vivo circulation and delivery to 
target tissues.  
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CHAPTER 2: CELL RIGIDITY AND SHAPE OVERRIDE CD47’s ‘SELF’ 
SIGNALING IN PHAGOCYTOSIS BY HYPERACTIVATING MYOSIN-II 
 
Abstract 
	  
A macrophage engulfs another cell or foreign particle in an adhesive process that often activates 
Myosin-II, unless the macrophage also engages ‘Marker of Self’ CD47 that inhibits Myosin.  
Adhesion processes of many cell types also activate Myosin and increasingly so on rigid 
substrates. Here we demonstrate that the rigidity of a phagocytosed RBC hyperactivates Myosin 
to overwhelm ‘Self’ signaling to macrophages. RBC stiffness is one among many factors, 
including shape, that change in senescence, some anemias, and diseases such as malaria. 
Controlled stiffening of normal human RBCs in different shapes did not compromise interactions 
of CD47 on RBCs with the macrophage ‘Self’-recognition receptor, SIRPA. Uptake of antibody-
opsonized RBC was always fastest with rigid RBC-Discocytes, which also showed maximal active 
Myosin at the phagocytic synapse and which biophysically out-competed ‘Self’ signaling by 
CD47. Rigid but more rounded RBC-Stomatocytes signaled ‘Self’ moreso than rigid RBC-
Discocytes, highlighting the effects of shape. Physical properties of phagocytic targets can thus 
modulate ‘Self’ signaling as seems relevant to splenic clearance of rigid red cells after storage or 
clearance of rigid pathological cells such as sickle and thalassemic red cells. 
 
Introduction 
	  
Factors that promote the cytoskeleton-intensive process of phagocytosis (Fig. 1A, left) are 
opposed by several inhibitory factors (Ravetch 2000) that ultimately dictate whether a 
macrophage engulfs a target cell or particle. Immunoglobulin-G (IgG) bound to a target engages 
Fcγ Receptor on a macrophage, for example, and coordinates the assembly of numerous 
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phagocytic synapse proteins (Vincente-Manzanares 2004, Swanson 2008, Flannagan 2012) 
including non-muscle myosin-II motors that help drive uptake (Olazabal 2002, Araki 2002, Tsai 
2008). If CD47 is displayed in parallel on a target, it binds the macrophage’s inhibitory receptor 
SIRPA (Jiang 1999), which activates the immunomodulatory phosphatase SHP-1 (Veillette 1998) 
that regulates multiple proteins (Okazawa 2005), including myosin-IIA (Baba 2003). Myosin-IIA 
inhibition at the phagocytic synapse could explain various observations that ‘Marker of Self’ CD47 
partially inhibits phagocytosis of mouse-RBCs (Oldenborg 2001) as well as normal white blood 
cells (Gardai 2005), stem cells (Blazar 2001), and cancer cells (Jaiswal 2009, Weiskopf 2013). 
Macrophage uptake of opsonized RBCs is also reported to contribute to clearance of RBCs in 
senescence (Kay 1975, Turrini 1991, Oldenborg 2000, Lutz 2004, Bosman 2008, Hod 2010) and 
in various diseases, including inherited anemias including sickle cell and thalassemia (Mohandas 
2008, Reliene 2002).  Aged and diseased RBCs differ from normal ones in physical properties 
such as rigidity (Chasis 1986, Mohandas 1994, Raat 2007); and stiffness also changes in cancer 
cells (Bercoff 2014, Lam 2007, Cross 2007), which could be important to broad anti-cancer efforts 
exploiting CD47-SIRPA interactions (Rodriguez 2013, Weiskopf 2013)12,17. Particle studies 
indeed show that stiff gel particles are engulfed in greater numbers than soft particles (Beningo 
2002), but relevance to cells with or without ‘self’ is untested. Normal human RBCs are 
controllably stiffened here in order to assess phagocytosis of rigid ‘self’ cells (Fig. 1A, right).   
 
As RBCs senesce, aldehydes are produced, which greatly accelerates RBC clearance from the 
circulation (Jain 1983) (e.g. Fig. S1A). While aldehydes react primarily with amines in Lys 
residues, which only occur in CD47 distal to its binding site with SIRPA (PDB: 2JJS), aldehydes 
can sometimes react with Arg (Salem 2010), which CD47 has in its binding site (Arg103) so that 
‘Marker of Self’ interactions might be inhibited. It is very clear that aldehyde-mediated cross-
linking of various RBC membrane proteins stiffens the cells (Fig. S1A). Rigid RBCs in healthy or 
disease states become stuck in narrow capillaries throughout the body (Ballas 1996, Tsai 2012), 
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especially splenic slits that impede rigid RBCs (Deplaine 2011), which could facilitate probing and 
clearance by splenic macrophages (Mebius 2005). Synthetic polymer ‘RBC mimics’ that lack any 
CD47 or other RBC proteins are also removed from circulating blood more rapidly when stiff 
compared to soft (Merkel 2011).  
Distinguishing physical enlodgement within blood vessels from enhanced phagocytosis has rarely 
been clarified in vivo, and a reasonable hypothesis examined here is that cell rigidity promotes 
phagocytic uptake by overwhelming CD47’s signaling of ‘Self’. Mechanistically, in the adhesion of 
most cell types to a planar substrate, a stiffer substrate activates myosin-II moreso than a soft 
substrate; and such activation drives polarization in hematopoietic stem cells (Shin 2014), cell 
spreading of neutrophils (Oakes 2009), and actomyosin stress fiber assembly in various 
fibroblastic cell types (Engler 2006).  Myosin-II is shown here to be hyperactivated by RBC rigidity 
and to oppose CD47’s ‘Self’ signaling, thereby increasing phagocytosis. The findings are broadly 
relevant to accelerated senescence and clearance after blood storage (Hod 2011), to anemias 
that affect red cell shape and rigidity, to phagocytosis of cancer cells, and even to synthetic 
particles used in vivo.    
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Materials and Methods 
	  
Reagents, cell lines, and standard methods are described in supplemental Methods. All blood 
was collected after informed consent with IRB approval at the University of Pennsylvania. This 
study was conducted in accordance with the Declaration of Helsinki. 
SIRPA Binding Assay Soluble SIRPA-Glutathione S-Transferase (GST) fusion protein was 
produced by transfection in COS cells. For some experiments SIRPA protein was cysteine linked 
to fluorophore. Red blood cells were isolated as in phagocytosis assays above. SIRPA was pre-
complexed with anti-GST, and incubated with RBC (30 min RT). Cells were pelleted and re-
suspended in 5% FBS/PBS, and analyzed with a BD LSRII flow cytometer. 
Preparation of RBCs  RBCs were isolated into 50 mM EDTA, plasma and buffy coat were 
removed, RBCs were washed with PBS, incubated with 0-50 mM Glutaraldehyde (GA) for 1 min 
at RT, and extensively washed. Prior to GA rigidification, GA-stomatocytes, were incubated with 
200 mOsm PBS (30 min) then treated with GA (50 mM, 200 mOsm,1 min, RT). For Antiserum 
and IgG opsonization, ≤10 µL packed RBC were incubated with 1-10 µL opsonin and CD47-
blocked with 1-3 µL anti-CD47.  RBCs were incubated shaking (Argos RotoFlex, 45 min, RT).  
RBCs were pelleted, and incubated with PKH26 (RT, 30 min). RBCs were counted by 
hemocytometer. 
Phagocytosis Assay (Microscopy) THP-1s were treated with 100 ng/mL phorbol-myristate-
acetate (PMA), for 2 days. Blebbistatin pre-incubation used 20 µM Blebbistatin at 37*C for 1 hour 
prior to RBC addition. RBCs were fed to macrophage at a ratio of 20:1, then incubated for 45 min 
at 37*C. Then cells were rinsed with PBS and fixed with 4% Formaldehyde. Non-ingested RBCs 
were differentiated by bound anti-rabbit–AF488 antibody. The phagocytosis index was calculated 
by counting the number of phagocytosed RBCs ≥200 macrophages, and expressed as the 
number of engulfed RBC per macrophage. 
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Phagocytosis Assay (Flow Cytometry) THP-1 macrophages and opsonized RBCs incubation 
were performed as in ‘Phagocytosis Assay (Microscopy)’. Macrophages were isolated for flow 
cytometry analysis: Wash 2x w. PBS, Add 0.5 mL H2O for 1 min, Trypsin Rinse followed by 
Trypsin incubation (5 min, 37*C) quenched with RPMI. Macrophage were isolated, centrifuged 
(3000G, 5 min), and resupended with Hoechst 33342 (10 min), centrifuged and resuspended in 
5% FBS/PBS and analyzed by a BD LSRII cytometer. 
Immunofluorescence of the Phagocytic Synapse THP-1 Macrophage were cultured on 
Nunc LabTek chambers, co-incubated with opsonized RBCs as in ‘Phagocytosis Assay 
(Microscopy)’, washed and fixed with 4% Formaldehyde, treated with Phalloidin-TRITC, Hoechst, 
anti-Myosin IIA, and anti-rabbit-AF488.  Images were acquired with an inverted microscope (IX71; 
Olympus) with a 60x (oil, 1.4 NA) objective using a cascade CCD camera (Photometrics). Image 
acquisition was performed with ImagePro (Media Cybernetics, Inc.). Intensity analysis of the 
phagocytic synapse was performed using imageJ with a 38 x 1 pixel box, where the synapse was 
aligned at the box center. Fluorescence intensity was normalized to the minimum signal, and 
averaged over ≥ 3 randomly selected synapses. 
Competitive in vivo Phagocytosis Assay RBCs were rigidified and opsonized as in vitro 
phagocytosis assays above. CD47+ and CD47-blocked RBCs were pre-treated with distinct 
lipophilic-dyes (PKH27 or DiR), mixed 1:1, and 2x107 RBCs were injected via tail vein to 
NOD/SCID/Il2rg−/− mice (NSG), following a protocol approved by the IACUC at the University of 
Pennsylvania. 15 minutes post-injection spleens were isolated, washed, treated with RBC-Lysis-
Bufer (Sigma 10min RT) and analyzed for IR intensity with a LI-COR Odysey (LI-COR). Flow 
cytometry differentiated splenic macrophage from splenocytes via Cd11b expression and each 
population was analyzed for RBC signal. 
Statistical Analysis  All statistical analyses were performed using GraphPad Prism 4. 
Unless otherwise noted, all statistical comparisons were made by unpaired two-tailed Student t 
test and were considered significant if P < 0.05.  
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Results 
	  
Rigid human RBCs bind SIRPA but are rapidly engulfed 
Normal human RBCs that are chemically modified with brief treatments of glutaraldehyde (GA) 
display functional CD47, as demonstrated by binding of both soluble SIRPA and a blocking anti-
CD47, B6H12 (Fig. 1B). Flow cytometry was used to measure binding and to also show that 
binding of soluble SIRPA to RBCs could be inhibited by pre-treatment of cells with B6H12 (Fig. 
1B, left inset). The recombinant GST-SIRPA used in these studies was detected either by pre-
complexing with fluorescent anti-GST44 or by direct fluorescence labeling of the reactive cysteines 
in GST, with the latter showing CD47 clustering (Fig. 1B, right inset) consistent with lateral 
mobility of a minor fraction of CD47 on human RBCs45.  
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Figure 1. SIRPA binds CD47 on both rigid and Flexible RBC 
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Figure 1. SIRPA binds CD47 on both rigid and native RBC.   (A).  Downstream of FcγR 
binding of IgG, kinases phosphorylate multiple cytoskeletal proteins, including myosin-II, which 
drive assembly of the phagocytic cup and promote uptake. CD47-SIRPA signaling leads to 
activation of SHP-1 phosphatase that can deactivate Myosin-II. Since, substrate rigidity initiates 
assembly and polarization of Myosin-II in many cell types, phagocytic target rigidity is expected to 
counterbalance CD47-mediated inhibition of the motor.  Our working hypothesis is that with 
flexible self cells (left), CD47 initiated inhibition can overcome myosin-II activation, whereas with 
rigid self cells (right), the myosin-II driven cytoskeleton is not diminished by CD47-SIRPA ‘self’ 
signals. (B) Binding of saturating concentrations of soluble human-SIRPA (GST conjugate) to 
human RBC treated with Glutaraldehyde (GA, 1 min at RT) shows no significant difference as 
compared to native RBC (green). High affinity mAb anti-CD47 (B6H12) also binds RBCs 
independent of GA concentration. Flow cytometry histograms (B, left inset) show SIRPA binds 
rigidified RBCs unless blocked by pre-treating RBCs with anti-CD47, indicating that SIRPA binds 
to CD47 (ns = not significant). SIRPA that is covalently labeled with fluorophore binds to rigidified 
cells (B, Inset images); the clustering suggests that CD47 is mobile (Scalebar: 5 µm). (C) 
Aspiration of RBCs into micropipettes similar in diameter to phagocytic cups and in vivo 
capillaries shows GA-treatment rigidifies cells and so does RT storage. The maximal RBC length 
and width under aspiration were quantified by image analysis and normalized by pressure and 
pipette cross-section (Native (green): n = 9, 17 mM-GA-Discocyte: n = 23, 50 mM GA-Discocyte: 
n = 2, error bar = SD). (* p ≤ 0.05 compare to Native, trendline R2 = 0.99). 
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For rabbit-RBC suspensions in fluid shear, the mean deformability of cells decreases 
exponentially with aldehyde concentration (Jain 1983) (Fig. S1A).  To assess cell-to-cell 
variability after GA treatment and on a scale similar to a phagocytic cup that forms in RBC 
engulfment, individual human-RBCs were aspirated here into micropipettes of slightly smaller 
diameter than the cells. All native RBCs were rapidly aspirated and highly distorted, whereas GA-
RBC always entered more slowly, deformed less, and with extreme GA treatment became stuck 
at the micropipette entrance (Fig. 1C, S1B).  The exponential decrease in single cell deformability 
index with GA is consistent with past bulk results for aldehyde-treated RBC in shear (Jain 1983), 
and the reasonably small cell-to-cell variations indicate uniformity of the reaction. In addition, 
RBC kept at room temperature for 1.5 days led to cell rigidification similar to a 17 mM GA 
treatment (Fig 1B). Such a treatment is not as extreme as time-and-temperature treatments that 
are already known to drive rapid clearance by the spleen (i.e. refrigerating at 4ºC for >1 mo or 
heating of RBCs to 50ºC for 20 min (Deplaine 2011)).   
 
Fresh RBC-discocytes normally possess a highly flexible membrane that extends easily under 
forces that even a few myosin motors might apply (~10 pico-Newtons (Mohandas 1994, Li 2005)).  
Time-lapse imaging of human-RBCs opsonized with anti-human-RBC anti-serum while being 
engulfed by human-derived THP1 macrophages showed that CD47-blocked RBCs undergo 
‘classical’ phagocytosis, with engulfment complete within five minutes after initial contact (Fig. 
2A). Regardless of whether CD47 is blocked or not, erythrophagocytosis begins with the 
macrophage pinching the RBC membrane into a semi-conical nascent synapse and causing the 
rest of the discocyte to become more spherical (Fig. 2A,B, S2A). Pinching of membranes is also 
evident at the beginning of phagocytosis of giant lipid vesicles that are subsequently ruptured 
(Fig. S2B). With RBCs, macrophage pseudopods then zipper along the membrane, constricting 
the erythrocytes in a manner expected to pressurize the hemoglobin-filled cytoplasm. Myosin-IIA 
contributes to cytoskeletal dynamics beneath the phagocytic cup (Araki 2002), and confocal 
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imaging confirms that an engulfed RBC is quasi-spherical with a diameter of ~6 um, consistent 
with a sphere of conserved cytoplasmic volume (Fig. 2A, Fig. S2). When CD47 is not blocked as 
on native RBCs, such engulfment to spherical completion is infrequent (≤ 25%). What is most 
often seen for native RBC is that macrophage-imposed deformations begin similarly, but are 
relatively larger and more sustained as CD47 signals ‘Self’ (Fig. 2B).  GA-discocytes are not 
deformable and are very rapidly engulfed (Fig. 2C). 
Regardless of self-signaling, extension of native RBCs that are being phagocytosed can provide 
estimates of the forces that macrophages exert in engulfment (Fig. S2C). Time-lapse images 
were quantified most simply in terms of the RBC’s projected length (Lp) along the phagocytosis 
axis and perpendicular to the synapse. Lp is initially ~8 mm, the diameter of a human-RBC 
discocyte (Fig 2D). When CD47 is functionally signaling ‘Self’, Lp increases the most up to ~12 
mm, thus stretching the RBC by ~50%. Pseudopods extend from the macrophage but do not 
surround the RBC at the distal end; the RBC deformation process seems similar to that reported 
for macrophages pre-treated with a myosin-light chain kinase inhibitor (Araki 2002) – which will 
prove to be no coincidence. With GA-rigidified RBC, the RBC is often flipped up and is then very 
rapidly engulfed, suggestive of rigidity-enhanced phagocytosis seen previously with polymer 
beads (Beningo 2002). The GA-RBCs contact the macrophage en face and seem to strongly 
adhere, but consistent with these GA-discocytes being rigid they do not become fully sphered in 
the phagosome as occurs with native RBC.  The frequency of ‘classical’ phagocytosis events in 
which engulfment vectors inward and the RBC does not greatly stretch is 100% for GA-discocytes 
and 75% for CD47-blocked native RBCs but only 25% for native RBCs signaling ‘Self’, and 
frequency versus engulfment time are linearly correlated (Fig. 2E).  Importantly, when native 
RBCs are encountered, the process is most often ‘non-classical’ with the large distensions 
persisting ~2-fold longer than the ‘classical’ trend and ~5-fold longer than uptake of rigid RBCs. 
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Figure 2. Phagocytic uptake of opsonized RBC is faster with CD47 inhibition but 
fastest for rigid RBC.  
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Figure 2. Phagocytic uptake of opsonized RBC is faster with CD47 inhibition but fastest for 
rigid RBC. Human-derived THP-1 macrophages were incubated with human-RBCs that were 
opsonized with anti-hRBC antiserum and also either:  (A) blocked with anti-CD47, (B) Native 
RBC with active CD47+, or else (C) rigidified as GA-Discocytes.  Time-lapse imaging in DIC and 
phase contrast begins with initial adhesion between macrophage and RBC targets, and ends 
upon complete engulfment.  The RBC of interest in each frame is colored blue, green, or pink. 
Scale bars: 8 µm. At the right of each of the time-lapse series, silhouettes of the target RBC 
clarify the changes in RBC morphology and position relative to the initial macrophage boundary, 
as indicated by the gray line, throughout engulfment. (D) The projected length (Lp) of the engulfed 
RBC along the phagocytosis axis shows that phagocytic deformation is fast and ‘classically’ 
vectored inward for rigid RBCs and for CD47-blocked RBCs compared to native RBCs (n ≥ 3 ± 
SD). When CD47 can signal ‘Self’, phagocytosis is much slower and Lp often increases (up to 
1.5-fold Lp0). (E) The percentage of classical uptake events for each RBC treatment is plotted 
versus the time required to complete engulfment, with the frequency of classical uptake showing 
a negative linear correlation with engulfment time (Line fit: R2 = 1.0).  Non-classical uptake is 
most frequently observed with Native RBCs that signal ‘Self’ and deviates from the classical trend 
by ≥2-fold. 
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Myosin-II localization to the Phagocytic Synapse is promoted by RBC Rigidity  
Adhesion to a rigid (not soft) substrate for many cell types drives cell spreading with assembly of 
stress fibers and polarization of non-muscle myosin-II (Shin 2014, Oakes 2009, Lo 2004, Raab 
2012); and Macrophages are certainly mechanosensitive in adhesion (Fereol 2006, Patel 2012, 
Blakney 2012) and phagocytosis (Beningo 2002). Target rigidity can therefore contribute to the 
generation of contractile forces during the phagocytosis of foreign cells.  Accumulation of myosin-
IIA at the phagocytic synapse between THP1 macrophages and opsonized human-RBC is largely 
inhibited by CD47 (Tsai 2008), as reproduced in a comparison of CD47-blocked native hRBC and 
native hRBC (Fig. 3A,B).  Rigid GA-discocytes, in comparison, show significantly greater 
accumulation of myosin-IIA within the macrophage distal to the human-human phagocytic 
synapse, and this apparent hyperactivation of contractility is completely inhibited by the myosin-II 
ATPase inhibitor blebbistatin (Fig. 3A,B).   
Actomyosin stress fibers are common in stromal cells such as fibroblasts while adhering to rigid 
plastic, but stress fibers are rare in macrophages.  Nonetheless, addition of the opsonized and 
rigid GA-discocytes caused a fraction of cells to assemble stress fibers that were not observed 
when native hRBC were added in identical numbers (Fig. 3C,D). Compared to native hRBCs that 
were CD47-blocked, rigid GA-discocytes induced the formation of straight and tensed (Tanner 
2010) stress fibers in 4-fold more macrophages, while addition of blebbistatin produced ‘relaxed’ 
arcs as seen in similarly treated myocytes (Sen 2011). Stress fibers were also induced in 
macrophages when CD47 was blocked.  
We had shown previously (Tsai 2008) that phosphorylation of tyrosines in myosin-IIA’s head and 
tail activate the motor, increasing its accumulation at the phagocytic synapse and increasing the 
efficiency of phagocytic uptake, while CD47-SIRPA’s activation of the tyrosine phosphatase SHP-
1 de-activates myosin-IIA (Fig. 3E). Indeed, an inhibitor of SHP-1 enhanced uptake of GA-
discocytes to levels similar to that of an anti-SIRPA antibody (Fig. S3A). Rigidity of a phagocytic 
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target thus tends to hyperactivate myosin-IIA in macrophages, and immunoblots against the 
myosin-IIA heavy chain in whole macrophage lysates after phagocytosis indeed show a high 
molecular weight form consistent with greater assembly of myofibers for rigid RBC than native 
RBC. Other sites of myosin-IIA phosphorylation include a serine residue (S9143) in the tail that 
limits filament assembly (Dulyaninova 2007) and reduces contractility in cells on soft substrates 
(Raab 2012). The high molecular weight myosin-IIA bands show no detectable phospho-S1943 
that is otherwise prominent in lower bands (Fig. S3B), which reinforces the conclusion that RBC 
rigidity promotes myosin-IIA assembly.
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Figure 3. Myosin II Accumulation at Phagocytic Synapse is strongly promoted by 
target rigidity and more weakly inhibited by CD47 
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Figure 3. Myosin II Accumulation at the Phagocytic Synapse is strongly promoted by 
target rigidity and more weakly inhibited by CD47. (A) The schematic (left) illustrates the 
intensity analysis that was performed on immunofluorescence images of the macrophage 
phagocytic synapse, where THP-1 were either pre-treated or not with the myosin-II inhibitor 
Blebbistatin (20 µM), followed by incubation with various anti-serum opsonized RBCs for 45 min 
at 37ºC, then fixed and immunostained for Myosin-IIA (green), F-actin (red), and DNA (blue) 
(Scale bar 10 µm). (B) Accumulation of Myosin II at the phagocytic synapse was quantified (n ≥ 3 
± SD), proving highest for rigid GA-Discocytes and, secondarily, for CD47-blocked RBC (*p < 
0.05). Blebbistatin suppresses Myosin-IIA accumulation to levels similar to Native RBC, denoted 
CD47+.  (C) Fluorescence images of F-actin and Myosin-IIA localization in macrophage fed either 
GA-Discs with or without pre-treatment with Blebbistatin (20 µM), or CD47-blocked RBC (Scale 
bar 30 µm). (D) Actomyosin fiber formation was quantified in macrophages, showing that GA-
Discocytes caused the highest frequency of cells with stress fibers. Blebbistatin pre-treated 
macrophages showed curved and relaxed fibers, whereas macrophages cultured with native 
RBCs do not show fibers. (D, inset) Western blot for non-muscle myosin IIA heavy chain, of 
macrophage lysates following phagocytosis, shows the presence of 230 kDa and 520 kDa bands, 
with the high molecular weight band consistent with stable myosin assembly. (E) Schematic of 
Myosin-II assembly in phagocytosis in which Myosin-II dimers assemble and contract actin 
filaments in response to rigidity of human RBCs, while becoming more disorganized in response 
to CD47-SIRPA mediated activation of immunoinhibitory phosphatase, SHP-1. Blebbistatin blocks 
the activity of myosin II ATPase, and thus the ability of the head to generate contractile forces, 
relaxing the stress fibers. The SHP-1 inhibitor NSC87877 reduces inhibition by CD47 and thus 
increases RBC uptake (Fig. S3A). 
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Rigid Discocytes are phagocytosed in greater numbers than flexible 
Discocytes   
Canine RBCs are opsonized by autologous IgG (Christian 1993) that increases 7-fold towards the 
end of the cell’s life span in vivo (Rettig 2014), with similar evidence for human RBCs that have a 
similar life span (Turrini 1991, Galili 1986). Aged human-RBCs lack other ‘eat me’ signals such as 
exposed phosphatidylserine (Franco 2012). Engulfment of native human-RBCs by THP1 
macrophages increases here with pre-opsonization of the hRBCs by an anti-hRBC antiserum, 
saturating at >10-fold higher levels than unopsonized hRBC (Fig. 4A). IgG concentration in 
serum is ~100 µM (Turrini 1993) and is 20% of total serum protein, but the highest IgG 
concentration used here is only ~1 µM with a fraction specific for human RBCs. Direct imaging of 
engulfed RBCs per macrophage at the end of the 45 min in vitro assay was done by scoring at 
least 100 randomly chosen macrophages, and for higher throughput, a flow cytometry assay was 
adapted (see Methods), and yielded the same relative phagocytic Index as microscopy, with 
normalization to uptake of native RBCs. Blocking hCD47 nearly doubles the uptake of native cells 
that are highly opsonized, but blebbistatin inhibition of myosin-II always produces uptake levels 
statistically similar to native hRBCs (Fig. 4B, left). Rigidified GA-discocytes are engulfed at 
similar levels as CD47-blocked native RBCs (Fig. 4B, right), while decreasing the GA treatment 
decreases phagocytosis (Fig. S3C) and follows an exponential trend consistent with the 
aldehyde-dependence of rigidification (Fig. 1C) and in vivo clearance (Fig. S1A). Remarkably, 
blocking CD47 on the rigid GA-discocytes shows no effect on engulfment (Fig. 4B, right).  In 
contrast, blebbistatin always inhibits uptake of GA-Discocytes (Fig. 4B, far right), with 
phagocytosis is reduced to levels similar to native RBCs that signal ‘Self’. The results thus 
indicate that increased uptake of GA-Discocytes and CD47-Blocked RBCs depends largely on 
active myosin-II.  
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At high opsonization, increasing amounts of anti-CD47 blocking antibody B6H12 promotes 
engulfment of native RBCs, saturating near the B6H12-independent engulfment of GA-discocytes 
(Fig. 4C). At low opsonization, the same increases in this anti-CD47 have no significant effect on 
the minimal engulfment of native RBCs (Fig. 4D, lower curve), which indicates that the B6H12 
antibody is not sufficiently abundant on hRBCs to contribute significantly to opsonization. On the 
other hand, the same low opsonization of GA-discocytes led to greater engulfment with 
increasing anti-CD47 (Fig. 4D, upper curve), which indicates that hCD47 is functional on these 
GA-treated cells, consistent with binding to soluble SIRPA (Fig. 1A).  Because we had previously 
shown hCD47 normally decreases splenic clearance in the NOD/SCID/Il2rg−/− (NSG) mice12, we 
injected stiff, highly opsonized hRBC into these mice to examine splenic clearance. The presence 
or not of anti-hCD47 blocking antibody B6H12 had no effect on splenic macrophage uptake (Fig. 
4E, S3E), consistent with in vitro results (Fig. 4C).  
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Figure 4. Rigid RBCs & CD47-Blocked RBCs both promote Opsonization-Driven 
Phagocytosis unless Myosin-II is directly inhibited 
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Figure 4. Rigid RBCs and CD47-Blocked RBCs both promote Opsonization-Driven 
Phagocytosis unless Myosin II is directly inhibited. (A) Phagocytic uptake shows an 
increasing and saturating response to anti-serum concentration. Here “high opsonization” is 
defined as a dose of opsonin greater than that required to result in half of the saturation level of 
engulfment. (B) All results were obtained for highly opsonized RBCs incubated with THP1s for 45 
min at 37ºC. A microscopy based phagocytosis assay indicates that native RBC were engulfed 
moreso when they were CD47-blocked, unless THP1 were also pre-treated with blebbistatin (20 
µM).  Rigidifed GA-Discocyte engulfment proved independent of CD47 blocking. However, 
engulfment of rigidified RBC was inhibited by pre-treating THP1s with blebbistatin. The gray bar 
highlights a baseline level of phagocytosis that is significantly higher than baseline when RBC 
targets are either CD47-blocked or GA-rigidified, where blebbistatin pre-treatment of both native-
blocked and rigid cells keeps uptake at this baseline (*p < 0.05). (C) At high opsonization, 
phagocytosis of GA-Discocytes is unaffected by blocking of CD47 (ns), while  (D) at low 
opsonization blocking of CD47 on GA-Discocytes does increase phagocytosis.  In contrast, for 
(C) deformable ‘Native RBCs’ at high opsonization, phagocytosis increases with blocking of 
CD47, whereas at (D) low opsonization, phagocytosis of native cells is insignificant regardless of 
blocking CD47 (ns).  The latter finding indicates that the anti-CD47 blocking treatment alone is 
not sufficient to drive engulfment of Native RBC.  For all experiments (*p < 0.05; n ≥ 3 ± SEM). 
(E) In vivo phagocytosis by splenic macrophages was assayed by injecting into NSG mice 
human-RBCs that were highly opsonized as in (C), rigidified (17 mM GA per Fig. 1C), and either 
CD47-Blocked or not (CD47+) as distinguishable after mixing by also labeling with spectrally 
distinct lipophilic dyes, DiR or PKH26 (swapped between mice, n=4). Spleens were isolated 15 
min post-injection and imaged, showing similar splenic numbers of DiR-labeled hRBCs for both 
CD47-Blocked and CD47+ hRBCs (Fig. S3E). After dissociation of spleens, splenic macrophages 
were distinguished from splenocytes using Cd11b expression. Whereas 1% of splenic 
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macrophage were positive for CD47-Blocked and for CD47+ hRBCs, positive macrophages with 
both hRBCs were rare (~0.01%) as were hRBCs in splenocytes (CD11b-).  
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The anti-CD47 dependencies of engulfment for highly opsonized native hRBCs and for low 
opsonized rigid RBCs fit to the same saturable binding curves (K = 90 nM and ~2.5-fold increase 
from baseline to saturation in Fig. 4C,D). Similar mechanisms of anti-CD47 activity are thus 
implied.  In the absence of any exogenous opsonization, engulfment is always low as expected, 
but (i) rigid GA-discocytes are engulfed more than native RBC and (ii) blocking with anti-CD47 – 
which impedes weakly adhesive interactions with macrophage SIRPA (Tsai 2008) – decreases 
engulfment of rigid GA-discocytes without affecting engulfment of native RBC (Fig. S3D). The 
results provide further evidence that CD47 is functional on GA-RBC, and seem consistent with 
CD47 acting as an adhesive ligand for cell tethering of apoptotic and/or damaged cells (Tada 
2003). However, whether cell stiffness changed in the cited studies and had any effect as seen 
here is unclear.  
 
RBC shape also modulates engulfment 
Changes in RBC shape during phagocytosis clearly decrease with RBC stiffness (Fig. 2), but 
whether the initial shape of the RBC influences engulfment and CD47 signaling is unclear and is 
certainly relevant to altered RBC shape in hereditary anemias (e.g. hereditary spherocytosis and 
sickle cells (Chasis 1986); and senescence (Bosman 2008). Moreover, since rigid polystyrene 
spheres displaying CD47 can signal ‘Self’ and inhibit phagocytosis (Tsai 2008, Rodriguez 2013), 
we generated and assayed more rounded and rigid RBCs. By treating RBCs with a mild 
hypotonic buffer prior to GA crosslinking, cells take on a morphology similar to that seen in 
hereditary stomatocytosis (Mohandas 2008, Da Costa 2013) (Fig. 5A inset, S4A). In patients, 
stomatocyte-spleen interactions were abnormally high but also reduced by a drug that decreases 
production of TNF-a (Smith 1997), which is often associated with upregulation of adhesion 
molecules on vascular endothelium (Janeway 2005). Rigid GA-Stomatocytes bind soluble SIRPA 
(Fig. S4B) similarly to GA-Discocytes (Fig. 1B), but the former signal ‘Self’ more effectively than 
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the latter. This is based on the observation that engulfment numbers increase with anti-CD47 
blocking at high opsonization using both anti-hRBC serum (Fig. 5A) and purified anti-hRBC IgG 
(Fig. 5B).  As with native RBC, immuno-blocking of CD47 on GA-stomatocytes increases the rate 
of engulfment as measured by time-lapse imaging (Fig. S4C). While inhibitory signaling is less 
effective than that seen with native cells, the GA-Stomatocyte results suggest a shift in the 
balance towards increased CD47 inhibition and away from rigidity induced myosin-II activation.  
 
Intriguingly, with anti-CD47, GA-Discocytes are engulfed similarly to GA-Stomatocytes with anti-
RBC antiserum (Fig 5A), while GA-Discocytes are engulfed less with purified anti-hRBC (Fig 5B). 
The latter result is consistent with IgG-opsonized “spheres” being phagocytosed more readily 
than “non-spheres” in studies of particles (Champion 2006).  
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Figure 5. Shape of Rigid RBC Modulates CD47’s “Don’t Eat Me” Signal. (A) RBCs treated 
with a hypotonic buffer followed by GA reaction generated rigid GA-Stomatocytes (inset image, 
left). Imaging of the macrophage phagocytic synapse with the stomatocyte shows pseudopods 
closely apposed to the rounded cell (inset image, right). With high opsonization by anti-serum, 
flow cytometry based phagocytosis assays of the more rounded GA-Stomatocytes showed less 
engulfment than GA-Discocytes in the absence of anti-CD47 blocking antibody, while blocking 
CD47 equalized uptake. (B) Anti-RBC IgG purified from anti-serum was used at similarly high 
opsonization for the RBC targets (inset D), but uptake of GA-Discocytes was low as compared to 
antiserum opsonized targets. Blocking of CD47, in this case, led to significantly greater 
engulfment of the more rounded but rigid GA-Stomatocytes compared to the GA-Discocytes.  For 
all experiments (*p < 0.05; n ≥ 5000 macrophage in duplicate, ± SD).  
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Native cells are also taken up moreso with antiserum opsonization as compared to purified IgG 
opsonization (Fig. S5). Antiserum contains additional opsonizing factors, particularly C3b 
(Janeway 2005), that induce complement-receptor mediated phagocytosis characterized by 
larger phagosomes in which the macrophage membrane loosely apposes the target 
(DeCathelineau 2003, Erwig 2008) with adhesion foci rather than dense adhesions per IgG-driven 
phagocytosis (Allen 1996). The complicated biconcave contour of a rigid GA-discocyte, and the 
resulting non-uniform membrane contact with a macrophage could make complement-driven 
uptake more efficient. 
 
 
Discussion 
 
CD47-SIRPA interactions at the macrophage surface somehow activate within the macrophage 
the tyrosine phosphatase SHP-1 (Jiang 1999) that targets multiple proteins including head and 
tail tyrosines in myosin-IIA’s heavy chain, making phagocytosis inefficient (Tsai 2008). Myosin-II 
in a broad range of adhesive cell types is also de-activated and stress fiber assembly suppressed 
by the softness of planar substrates (Shin 2014, Engler 2006, Lo 2004, Rehfeldt 2012). 
Macrophages certainly exhibit similar mechanosensitive adhesion (Fereol 2006, Patel 2012, 
Blakney 2012) as well as reduced phagocytosis of soft synthetic spheres (Beningo 2002).  The 
balance studied here between CD47-SIRPA signaling against phagocytosis versus rigidity and 
shape of human RBC promoting phagocytosis is summarized in a structure-function heatmap of 
normalized results (Fig. 6A).  The few differences in uptake evident for native RBC versus rigid 
GA-Discocytes when myosin-II is inhibited most simply reveal ‘classical’ uptake of GA-RBC 
without red cell deformation and also a tendency of GA-Discocytes to stimulate stress fiber 
assembly even though myosin-IIA’s ATPase is inhibited. At the opposite end of the heatmap, 
blocking of CD47 has little effect on uptake of GA-Discocytes (compare ‘Blocked’ to CD47+), with 
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a slight attenuation of the uptake phenotype for ‘Blocked’ cells perhaps reflecting the fact that 
blocking impedes the weakly adhesive interactions of CD47 with macrophage SIRPA (Tsai 2008).  
Native CD47-blocked RBC show an intermediate heatmap profile but group more with the rigid 
GA-Discocytes, consistent with strong myosin-II activation. 
 
For all of the various RBC targets, IgG on the RBC is likely recognized by the macrophage 
receptor FcγRIIA, which triggers phagocytic cup formation independent of Myosin-II (Fig. 6B). 
While subsequent internalization depends on myosin-II (Olazabal 2002), the flexible native RBC 
show that CD47-SIRPA inhibition dominates the opsonization signaling that otherwise activates 
myosin-II. Blocking CD47 on soft RBCs leads to the characteristic hour-glass deformations seen 
when discocytes from different species are engulfed69, consistent with CD47-SIRPA interactions 
being species specific (Tsai 2008, Subramanian 2006, Takenaka 2007).  
 
Macrophages cannot deform GA-rigidified discocytes, which induces Myosin-II activation, 
assembly, and accumulation at the phagocytic synapse, contributing to rapid rotation of the target 
in ‘en face’ ingestion.  Loss of RBC deformability seems to contribute to rapid clearance of RBCs 
from the circulation (Deplaine 2011)), consistent with rapid removal of relatively rigid apoptotic 
bodies (DeCathelineau 2003, Erwig 2008), but the relative contributions of cell stiffness, opsonin 
density, and even the roles of macrophages are rarely clear.  Rapid uptake can limit signaling 
from other receptor-ligand interactions as can a rigid discocyte’s concave shape, which can also 
limit contact between the macrophage’s nascent phagosome membrane and a target membrane 
(Fig. S4D). A more spherical RBC shape indeed rescues CD47-SIRPA mediated signaling 
consistent with the more tightly apposed myosin-rich projections seen with rounded GA-
stomatocytes (Fig. S4D).  Rigid polystyrene spheres with CD47 attached likewise signal ‘Self’, 
minimizing macrophage uptake in vitro and in vivo while also suppressing myosin-IIA localization 
to the phagocytic synapse (Rodriguez 2013).  
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Loss of deformability of aged erythrocytes has long been thought to contribute to their clearance 
from circulation, with additional determinants possibly including partial loss of CD47 (6-50%(Annis 
2002, Kamel 2010)) and also oxidation of CD47 (Olsson 2008, Burger 2012).  The results here 
clarify the complementary role that target deformability plays in clearance by tissue macrophages, 
with findings relevant perhaps to chemotherapy-rigidified leukemias, rigid-walled microbes (yeast 
and bacteria), and particles used in gene and drug delivery as well as the well-known rigid red 
cells that result from blood storage and that occur in common diseases such as sickle cell and 
thalassemia. 
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Figure 6. Myosin II Activity at the Phagocytic Synapse with Opsonized Target is 
Inhibited by CD47 but enhanced by Target Rigidity 
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Figure 6. Myosin II Activity at the Phagocytic Synapse with Opsonized RBC Targets is 
inhibited by CD47, while Enhanced by Target Rigidity. (A) Heatmap summary of normalized 
phagocytosis and immunofluorescence results (Multi-Experiment Viewer Software). The 
dendrogram of hierarchical clustering using the Euclidian distance metric indicates that   
macrophage response to rigid GA-discocytes is distinct from that of native RBC targets and that 
blocking CD47 on deformable RBCs (but not on GA-Discocytes) reduces the difference as does 
blebbistatin pre-treatment of macrophages encountering GA-Discocytes (GA-Disc CD47+ 
Blebb+). CD47 inhibition is partially rescued with rigid but rounded GA-stomatocytes (GA-Stom 
CD47+), unless CD47-Blocked (GA-Stom CD47-). (B) Macrophage recognition of IgG opsonin on 
the surface of RBC by FcγR phagocytic receptors activates cytoskeletal proteins including 
Myosin-II. Signaling via SIRPA to phosphatases does occur with CD47 on either flexible ‘Self’ 
cells or sufficiently rounded but rigid ‘Self’ cells. RBC rigidity has the effect of rapidly and strongly 
activating adhesion and myosin-II contractions. Rigid discocytes maintain their shape throughout 
engulfment, which limits contact between macrophage receptors and ligands, particularly SIRPA 
and CD47 on the RBC.  
 
47	  
	  
 
Supplementary Materials and Methods 
 
Cells, Reagents, and Antibodies THP-1 macrophage (American Type Culture Collection 
and European Collection of Cell Cultures) were cultured in RPMI (Invitrogen) supplemented with 
10% FBS (Sigma). Differentiation of THP-1 cells was achieved in 100 ng/ml phorbol myristate 
acetate (PMA) (Sigma-Aldrich) for 2 d and confirmed by attachment of cells to culture vessel. For 
microscopy based phagocytosis assays macrophage were cultured in 4-cm2 Lab-Tek chambered 
coverglass (Nunc International), and for flow based phagocytosis assays macrophage were 
cultured in 6-well plastic dishes (Corning). Dulbecco’s phosphate-buffered saline (DPBS) without 
Ca2+ or Mg2+ (Invitrogen) was supplemented or not with BSA  (Sigma-Aldrich). PKH26 (Sigma-
Aldrich) was used for erythrocyte cell labeling. RBC opsonins included Anti-human RBC antibody 
(rabbit, Rockland Pharmaceuticals) and Anti-human RBC IgG (rabbit, Rockland 
Pharmaceuticals). Anti-CD47 mAb clone B6H12 (BD Biosciences) was used to block CD47. 
Secondary antibodies used to detect bound opsonins included Donkey Anti-rabbit IgG conjugated 
with AlexaFluor 488 or AlexaFluor647 was used to detect opsonin. Anti-Myosin IIa was used in IF 
of the Phagocytic synapse  (mouse Abcam). Anti-Myosin IIa (rabbit Sigma) was used in  
actomyosin fiber analyses and western blotting. Hoechst 33342 (Invitrogen) was used to identify 
the macrophage nucleus. Reagents used to detect F-actin included Phalloidin conjugated with 
AlexaFluor 488 (Invitrogen) or TRITC (Sigma). Racemic Blebbistatin was used in phagocytosis 
assays (EMD Biosciences). 
 
Micropipette Aspiration Capillary tubes were pulled into micropipettes and trimmed by 
microforge (Vibratome) to mean diameter ~6 µm. Micropipettes were attached to a dual-stage 
water manometer with adjustable height reservoirs. Suction was applied by syringe, and pressure 
measured by transducer (Validyne). Pipettes pre-rinsed with 3% BSA were used to aspirate 
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RBCs (200 Pa), imaged (Nikon TE300) with 40x objective, captured with Cascade CCD camera 
(Roper Scientific), and analyzed with ImageJ. 
 
Time Lapse Microscopy Phase-contrast imaging was performed in a humidified chamber 
at 37*C and 5% CO2 using an inverted microscope (Olympus IX-71) with a 40x objective (NA 0.6) 
and high-resolution CCD camera (CoolSNAP HQ; Photometrics). softWoRx [DeltaVision] was 
used for image-capture. DIC imaging was performed in a temperature-controlled chamber with 
THP-1 cultured in HEPES buffered RPMI, using an inverted microscope (Leica TCS SP5) with a 
63x water-immersion objective (NA 1.2). Time-lapse imaging was initiated when a RBC adhered 
to a macrophage. ImageJ was used to analyze dimensions of RBC during engulfment.  
 
Confocal Microscopy Macrophage and RBC were co-cultured in 4-cm2 Lab-Tek chambered 
coverglass (Nunc International) were imaged using an inverted microscope (Leica TCS SP5) with 
a 63x water-immersion objective (NA 1.2). Anti-Rabbit IgG conjugated to AlexaFluor647 was 
excited with a He Ne laser at 633 nm, and emission was collected in the range of 650-720. 
Phalloidin-AlexaFluor488 was excited with an argon laser at 488 nm, and emission was collected 
within 500-550 nm. DiIC18 was excited with DPSS laser at 561 nm, and emission was collected 
within 600-650 nm, and DAPI was excited with the multiphoton laser at 730 nm, and emission 
was collected between 400-460 nm. Bidirectional scanning with a correction factor of -27 was 
used with a line average and frame average of 3. 
 
Western Blotting THP-1 macrophages were plated at 2E5 cells per well of a 6 well plate 
(Corning), and fed RBC at a ratio of 1 macrophage to 20 RBC. RBC conditions were, native, 
native-CD47-block, GA-Discocyte, and GA-Discocyte with Blebbistatin (20 uM). Cells were lysed 
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with ice-cold RIPA buffer supplemented with 1% protease inhibitor, 1% phosphatase inhibitor, 
and 1% Vanadate. For every 100 up of lysates, 30 up of LDS, and 5 up of Beta-ME were added 
prior to heating on heating block for 10 min at 70*C in water. 1 x 6 well plate was lysed for each 
condition, and equal volume of lysates was loaded in each lane of 3-8% Tries Acetate gel. 
Proteins were transferred to PVDF membranes, and blocked with 5% milk in TBS (m/v). 
Membranes were blotted for pS1943 (rabbit, Cell Signaling) and Nonmuscle Myosin-IIA (rabbit 
pAb, Sigma), and probed with anti-rabbit-HRP secondary, followed by chromosensor detection.  
 
Vesicle Preparation Giant vesicles composed of 1-palmitoyl-2-oleoyl-Glycero-3 
phosphocholine (POPC) (Avanti) with <1% DiIC18 were prepared by electroformation.  5 uL of 
POPC/DiIC18 stock (10 mg/mL) was transferred to cleaned ITO glass slides with a Hamiltonian 
syringe, spread over the glass with the syringe tip, dried in fume hood for 2h. ITO glass slides and 
spacer were assembled and fill with an osmotically adjusted sucrose solution (340 mOsm). The 
apparatus was then treated with a sinus wave with voltage of 1.4V (RMS) and frequency of 10 Hz 
for 1.5 hours. Vesicles were equilibrated to ambient conditions 1h before transferring to glass vial. 
For phagocytosis assays, GUVs were pre-incubated with 10 µl anti-RBC antiserum (30 min, RT). 
 
50	  
	  
Supplemental Figures  
 
Figure S1. Rigid Cells show reduced in vivo circulation and reduced in vitro 
aspiration speed   
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Figure S1. Rigid Cells show reduced in vivo circulation and reduced in vitro aspiration 
speed.  (A) In studies of Jain et al. (1983) rabbit RBC were treated with 0-80 µM 
Malondialdehyde (MDA) for 1 hour at 37ºC, and measurements of RBC deformability in bulk 
shear by ektacytometry demonstrated an exponential decay with MDA, Deformability Index (DI) = 
101*exp(-[MDA]/17.5 µM), R2=0.999. (inset) The in-vivo circulation half-life positively correlates 
with DI (Jain 1983), fitting to thalf = 5.2 DI2. (B) GA treated RBCs were aspirated in micropipettes 
similar in size to phagocytic cups. Aspiration rate was quantified and normalized relative to the 
rate of native cell aspiration. The number of cells that were fully aspirated versus the number that 
became stuck at the pipette entrance was quantified and annotates each data point. 
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Figure S2A. During classical phagocytosis, the hRBC is first pinched, then 
elongated, and finally spherical after engulfment  
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S2B. Phagocytic Deformations quickly Rupture Lipid Vesicles 
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Figure S2.C Deformations of Native RBCs indicate the forces that Macrophages 
exert on RBC during engulfment 
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Figure S2. During classical Phagocytosis the hRBC is first pinched, then elongated, and 
finally spherical after engulfment. (A) (i) Schematic of classical deformations. (ii) Confocal 
images of macrophage cytoskeleton (Phalloidin-AF488) and RBC (anti-RBC) during the initiation, 
midpoint, and completion of phagocytosis were quantified for length (iii). The length to width ratio 
(iv) indicates that the RBC becomes circular during initial engulfment, and following engulfment. 
(B) Kinetics of deformation during lipid vesicle phagocytosis and rupture. The deformation along 
the length and width of the vesicle (i) as well as the corresponding change in mean intensity of 
lipid vesicle (ii) indicate in quantitative terms that the vesicle shrinks after rupture followed by 
rapid aggregation of the lipid vesicle in the surrounding aqueous cell culture medium. Schematic 
inset in (i) indicates lipid vesicle deformation. (iii) Time-lapse imaging shows phagocytosis and 
rupture of antiserum-opsonized POPC-DiIC18 lipid vesicle where the macrophage pseudopods 
can be seen co-localizing with the lipid vesicle and the lipid vesicle membrane increases in 
intensity suggestive of aggregation or pinching of the lipid vesicle membrane. At 64 seconds post-
initial contact, the lipid vesicle decreases in size, and finally aggregates before leaving the plane 
of focus. (iv) In a second time-series, a lipid vesicle was contacted by pseudopods of two 
different macrophages. The green box at 3.9 sec highlights where the macrophage has deformed 
the lipid vesicle and the blue box at 24.3 sec highlights where a macrophage appears to have 
engulfed a portion of the ruptured vesicle and a piece of stretched membrane can be seen 
adjacent to the engulfed clump. Zoomed in versions of the green and blue boxes are to the right 
of (iv). (C) The Deformation of Native and CD47-blocked RBCs imposed by the macrophage 
cytoskeleton during phagocytic engulfment were quantified. (i) The x-axis is defined to be in the 
direction of movement of RBC towards M.  Deformations are typically 50% in the x-direction so 
Green’s strain was used to describe strain, which acts across the length of the red cell to give the 
resultant force in the x-direction. (ii) The force imposed by macrophage, FΜΦ which is defined here 
as equal to the resultant deformation force in the x-direction, Fx, was quantified throughout the 
engulfment process, and was found to have a maximum from 60-120 pN. This non-classical FΜΦ is 
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expected to be relatively myosin-II independent, and the force is generated instead by other 
components of the cytoskeleton such as F-actin. 
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Figure S3 Further Exploring the Mechanism by which Rigidity Affects CD47-SIRPA 
Mediated Inhibition. 
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Figure S3. Further Exploring the mechanism by which rigidity affects CD47-SIRPA 
mediated Inhibition. (A). At intermediate levels of antiserum, CD47 can inhibit uptake of 
aldehyde rigidified RBC, as treatment with a CD47-blocking antibody increases uptake. This is 
similar to the result of CD47-blocking GA-discocytes at low antiserum (Fig 4D). Pre-treating 
macrophage with anti-SIRPA also increases uptake to magnitude similar to anti-CD47. SHP-1 
inhibitor (60 nM) also increases uptake. (B) Western Blots for Myosin-IIA and Phosphorylation 
Myosin II Serine Residue 1943 were performed.  (C) A flow cytometry based phagocytosis assay 
was performed on high antiserum opsonized GA-discs treated with a range of GA concentrations, 
and indicates that phagocytosis increases exponentially with GA concentration. (D) A flow 
cytometry based phagocytosis assay of unopsonized native and GA-Discocytes indicate blocking 
CD47 inhibits uptake, consistent with CD47 acting as an adhesive tether, and further that CD47 is 
functional in support of SIRPA binding studies (F1A). (E) A competitive in vivo phagocytosis 
assay was performed where highly opsonized and rigidified GA-discocytes (17 mM) that were 
either CD47-blocked or not were co-injected and differentiated by spectrally-distinct lipid dyes. 
Spleens that were injected either CD47+ DiR RBC with CD47-blocked PKH26 RBC or CD47-
Blocked DiR RBC with CD47+ PKH26 RBC were analyzed for IR intensity by LI-COR (excitation 
800 nm).  The number of engulfed RBCs was calibrated from the LI-COR measured IR intensity 
of a dilutions series of pre-injected blood. CD47- blocking did not affect the RBC localization to 
the spleen with CD47+ and CD47-blocked RBC injected spleens, and calibration gives an 
estimated mean of ~4 x 104 DiR-huRBCs per spleen. Combined with results in the bar graph of 
Fig.4E, ~4 x 104 RBC were engulfed by 2% of total splenic macrophages, predicting that the 
murine liver contains ~2 x 106 macrophage. This macrophage number seems consistent with 
literature that indicates typical murine liver contains ~107 macrophage, and total liver versus 
spleen macrophages are in a ratio of 3.2, so that murine spleen has ~3 x 106 macrophages.  
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Figure S4. Characterization of GA-Stomatocyte 
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Figure S4. Characterization of GA-Stomatocyte (A) Phase contrast imaging of GA-
stomatocytes and GA-Discocytes. GA-stomatocytes are more rounded than GA-discocytes. (B) 
SIRPA binding to GA-stomatocyte is similar to native, and can be inhibited by pre-treatment with 
B6H12. (C) CD47 blocking increases the rate of phagocytosis of native cells that become 
rounded during engulfment, and of rounded GA-stomatocytes. In contrast, CD47 blocking 
increases the rate of engulfment of GA-discocytes. (D) Fluorescence imaging of the macrophage 
synapse with GA-discocyte shows that the macrophage pseudopods can be loosely apposed to 
the GA discocyte surface while the synapse with GA-stomatocyte shows tightly apposed myosin-
rich pseudopods.  
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Figure S5. Uptake of IgG Opsonized Native RBC. A flow cytometry based phagocytosis assay 
of purified IgG-opsonized native RBC relative to purified IgG opsonized GA-discocytes (as in Fig 
5B) was performed. Similarly to GA-Discocytes, and in contrast to GA-stomatocytes, uptake of 
purified IgG opsonized native-RBC is reduced relative to anti-serum opsonized native RBC.  
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CHAPTER 3: LENTIVIRAL DISPLAY OF ‘MARKER OF SELF’ CD47 
DECREASES MACROPHAGE UPTAKE OF VIRUS AND INCREASES 
CIRCULATION FOR DELIVERY TO TUMORS  
 
Abstract 
	  
Lentiviruses infect many cell types with high efficiency and are now widely used for gene delivery 
in vitro, but in vivo uptake of these foreign vectors by macrophages limits broader application. 
Lentiviruses (Lentis) are generated here from packaging cells that overexpress CD47, which 
partially inhibits phagocytosis of multiple human and mouse cell types when the cells also present 
pro-phagocytic factors. Single particle analyses show that ‘hCD47-Lenti’ display properly oriented 
human-CD47 for interactions with the phagocyte inhibitory receptor SIRPA. Macrophages derived 
from human and NOD/SCID/Il2rg−/− (NSG) mice show a SIRPA-dependent decrease in 
transduction by hCD47-Lenti compared to Control Lenti, whereas human lung epithelial cells are 
efficiently transduced by hCD47-Lenti. Macrophage transduction by the Control Lenti is also 
decreased by pharmacological inhibition of Myosin-II to the same levels as hCD47-Lenti, 
consistent with ‘Self’ signaling pathways established previously for phagocytosis of cells. 
Systemic injection of hCD47-Lenti into NSG mice shows hCD47 prolongs circulation, unless a 
blocking anti-SIRPA is pre-injected, and in vivo transduction of spleen and liver macrophages is 
also decreased whereas transduction of xenografted tumor cells increases. Display of hCD47 
could prove useful on other viruses when macrophage uptake is limiting. 
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Materials and Methods 
	  
Reagents, DNA constructs, cell lines, and standard methods are described in 
supplemental Methods. 
Generation of HEK-CD47-GFP Producer Cell Line HEK 293T cells were transduced with a 
lentiviral vector encoding CD47-GFP and puromycin resistance transgenes. Lentiviral 
transduction was followed by puromycin selection for 3 weeks. To produce the CD47-Lenti, the 
HEK CD47-GFP cells were transfected using standard methods.  
In Vitro Transductions Cells were plated at 1x104 cell/cm2. Lentivectors were added at an MOI 
from 10-2000. Where MOI (multiplicity of infection) is the ratio of the number of vectors to number 
of cells. Macrophages and lentivector were co-incubated for 1 hour. 3 days post-transduction, 
cells were assayed for reporter gene expression by fluorescence microscopy. Total cell number 
was determined by DNA stain (Hoechst). Where indicated, cells were pre-treated with anti-human 
SIRPa (clone SE7C2) or with anti-mouse SIRPa (clone P84) 15 minutes prior to transduction. 
Where indicated, cells were pre-treated with Blebbistatin (5-50 µM) for one hour prior to 
transduction. Anti-SIRPA and Blebbistatin incubations continued throughout the duration of the 1 
hour lentivector-cell incubation. 
In Vivo Injections and Sampling 3x108 to 1x109 lentivirus were injected via tail vein of 
NSG mice. Blood was sampled via retro-orbital bleed at 10 min, 45 min, and 24 hours post-
injection and analyzed by functional titer (Supplementary Methods). 4-5 days post-injection 
spleen, liver, and flank tumors were collected for immunohistochemistry analysis, or flow 
cytometry analysis of reporter gene expression (DsRed.MST). 100 µg of anti-mSIRPA (P84) was 
pre-injected 30 minutes prior to injection of lentivector for in vivo SIRP blocking studies. 
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Introduction 
 
Viral delivery of genes can be extremely efficient in vitro (Naldini 1996), and many therapies are 
now emerging with Lentiviral vectors (Lentis) (Consiglio 2004, Worsham 2006, Lee 2009) 
including recent clinical trials (Cartier 2009, Frecha 2012, Aiuti 2013).  However, in vivo therapies 
with Lenti are challenged by clearance into macrophages, which take up all types of foreign 
particles (Scherphof 2006, Rodriguez 2013). As a consequence, the vast majority of a Lenti-
delivered transgene is expressed in these phagocytic cells of spleen, liver, and bone marrow 
(Pan 2002, Follenzi 2002). Immunohistochemical analysis of livers of Lenti-injected mice has also 
confirmed expression in the Kupffer cells, which are the dominant liver macrophages (van Til 
2004) that derive from bone marrow (Klein 2007). Uptake by macrophages is generally enhanced 
by opsonins such as IgGs (Montalvao 2013, Takeda 1990) that can physisorb to virus during 
production in serum and/or post-injection (DePolo 2000), and uptake is also enhanced by the 
commonly used Lenti envelope protein, VSV-G (Farley 2007). Acute or chronic inflammatory 
responses initiated by vector components can occur after macrophage uptake (Brown 2007, 
Rossetti 2011). Reducing viral clearance by the innate immune system has been attempted by 
modification with polymers (Croyle 2004) analogous to the so-called ‘stealth’ coatings that delay 
opsonizing deposition of serum proteins and subsequent clearance of liposomes (eg. Semple 
2000). However, such polymer brush coatings will tend to obscure VSV-G and other envelope 
proteins that seem useful for targeting viruses to non-phagocytic cell types (Yang 2008, 
Padmashali 2011, Hwang 2013, Verhoeyen 2004, Pariente 2007). 
 
CD47 is an integral membrane protein found on all human and mouse cells, and its 
immunoglobulin-like N-terminal domain is a ligand for an immunoinhibitory receptor SIRPA that is 
abundant on macrophages (Jiang 1999). SIRPA activates the phosphatase SHP-1 (Veillette 
65	  
	  
1998), which represses the otherwise efficient phagocytosis of cells and large particles when 
opsonized with IgG and complement among other antagonistic factors (Anderson 1990, Tsai 
2008). By this pathway, CD47 acts as a ‘Marker of Self’ as originally described when CD47-
deficient red cells were injected into control mice and found to be rapidly cleared by splenic 
macrophages (Oldenborg 2000). As the capsid of an enveloped-type virus buds through a host 
cell membrane, the virus membrane can in principle incorporate various integral membrane 
proteins and maintain protein orientation (McLellan 2011). We hypothesized that full-length 
hCD47 could be displayed sufficiently on the envelopes of Lenti to specifically signal against 
macrophage uptake of these complex particles. For in vivo studies, NOD/SCID/Il2rg−/− (NSG) 
mice are used because these mice express a unique mouse variant of mSIRPA that binds 
human-CD47 (Takanaka 2007), and we show that CD47-Lenti exhibit enhanced circulation and 
gene delivery to a model disease site in these mice. The findings illustrate an approach with 
highly specific ‘anti-targeting’ to avoid innate immune macrophages.   
 
Results  
 
Virus Display of ‘Marker of Self’ CD47 
Human-derived HEK 293T cells are widely used to package lentiviral vectors (Naldini 1996), and 
transduction of this epithelial cell line with a human CD47-GFP construct shows the GFP signal is 
predominantly at the plasma membrane (Fig. 1A). Immunostaining of fixed but non-permeabilized 
cells with an antibody to hCD47’s extracellular Ig domain further shows a maximum intensity at 
cell-cell junctions where the antibody can in principle cross-bridge hCD47 in trans between two 
membranes. CD47-GFP on epithelial cells is already known to be highly mobile (Subramanian 
2007), which should be conducive to integration into viral envelopes. Flow cytometry 
measurements of anti-CD47 intensity on the transduced cells indicated >10-fold higher CD47 
density than that of control cells (Fig. S1A), and mass spectrometry analyses of the ‘HEK CD47+’ 
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cells also detected three peptides from the human Ig domain with a mean ion current that was 
again >10-fold that of control cells (Fig. S1B).  
 
Since red cell circulation relies on CD47 (Oldenborg 2000), a direct comparison with HEK 
producer cells was sought. The much smaller human red cell has ~25,000 molecules of hCD47 
per cell (Mouro-Chanteloup 2003), and from image-based estimates of mean surface areas of 
RBC (Fung 1993) and HEK cells (Sommerhage 2008), calculated densities of hCD47 on RBCs 
and HEK CD47+ cells prove similar (Fig. S1C). Control HEK cell membranes not only display 
much lower hCD47 density, but their hCD47 density is below the levels needed for inhibition of 
macrophage uptake based on studies of recombinant hCD47 Ig domain on opsonized beads 
(Tsai 2010, Rodriguez 2013). Control Lentis that bud from conventional HEK cells are therefore 
unlikely to signal ‘Self’ with hCD47, but viruses that bud through the HEK CD47+ membranes can 
in principle display abundant hCD47 (Fig. 1B)  
 
Lentiviral supernatants made by transfecting HEK-CD47 cells with standard plasmids (Methods) 
were concentrated by ultracentrifugation and then immobilized on coverslips pre-coated with anti-
CD47 in order to image GFP containing particles. High-resolution Total Internal Reflection 
Fluorescence Microscopy (TIRFM) revealed mostly nano-sized fluorescent particles (Fig. 1C, 
S2A), and control particles were not fluorescent. Distributions of particle intensities were 
dominated by a single population (Fig. S2B, C) as were particle height distributions determined 
by atomic force microscopy, which gave a ~120 nm peak (Fig. S2D, E) that is consistent with 
dimensions of standard lentivirus (Koi 2007, Fuller 1997, Dorfman 1994, Reicin 1996, Nakai 
1996).  Photobleaching of GFP occurred over minutes and showed no evidence of single 
molecule step-wise bleaching (Fig. S2F), which indicates at least a dozen or more CD47-GFP 
molecules per particle and seems consistent with 90-260 nm particles having CD47 densities 
similar to the producer cells (~7-60 molecules per spherical virus). Importantly, ~70% of attached 
GFP particles were also double-positive for acridine orange, which permeates membranes and 
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fluoresces red when bound to single stranded RNA or DNA (Fig. 1C) – as expected for the 
ssRNA genome of lentivirus (Desport 2010). Immobilization of the intact CD47-lenti to glass 
coverslips was also observed only with antibody to hCD47’s Ig domain and binding occurred in 
minutes, whereas anti-GFP and non-specific antibody showed little to no immobilization of 
particles even after incubations of hours (Fig. 1D). The lack of binding of anti-GFP suggests this 
C-terminal epitope is within the lentiviral envelope as expected, whereas CD47’s Ig domain is 
outward oriented on the virus and thus available for binding SIRPA.  
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Figure 1. Virus Display of ‘Marker of Self’ CD47 
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Figure 1. Novel Lentivector Displays CD47-GFP   (A) In HEK-CD47-GFP Producer cells the 
CD47-GFP (green) and anti-CD47 (red) signals are localized to the cell periphery, distinct from 
the nucleus (Hoechst, blue). CD47-GFP signal colocalizes with anti-CD47 immunostaining of the 
HEK-CD47-GFP cell membrane. (B) Lentiviruses are enveloped viruses, where the viral capsid 
and genome self-assemble beneath the cell membrane and the assembled lentivirus then buds 
taking a piece of the cell membrane as the viral envelope. (C) HEK-CD47 lentiviral transfection 
supernatants were incubated with anti-CD47 coated coverslips, and adherent material was 
stained for acridine orange, which co-localized with the CD47-GFP fusion protein. (D) CD47-lenti 
binds IgG coated glass in an anti-CD47-dependent and anti-GFP independent manner (n≥3, 
p≤0.05).  
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Equilibrium density gradient ultracentrifugation of CD47-Lenti supernatants should separate the 
relatively dense capsid-containing virions from lighter cell debris, vesicles, and media 
components (Dettenhoffer 1999). Such a separation was confirmed by assays for functional titer 
of infectious virus in HEK cells (Fig. S3A-C); the virally delivered transgene in these and all 
studies below is a CMV-promoter driven RFP variant DsRed.MST (Vinterson 2004, Bevis 2002), 
which allows quantitation of fluorescent cells. Coomassie-stained SDS-PAGE separations of 
ultracentrifuged fractions suggested that functional virus contained both CD47-GFP and the p24 
protein that makes up the viral capsid (Zhao 2013), with CD47-GFP being confirmed by anti-GFP 
immunoblotting (Fig. S3D,E).  
 
CD47 inhibition of Macrophage Transduction & Enhancement of A549 
Transduction 
Macrophage transduction by CD47-Lenti versus control Lenti was assessed first with human-
derived, PMA-differentiated THP1 cells at a vector to cell ratio (i.e. multiplicity of infection, MOI) 
that ranged from 10 to 2000 (Fig. 2A).  At intermediate MOI, CD47-Lenti transduced ~3-fold 
fewer macrophages than control lenti; and across the entire range of MOI’s, standard hyperbolic 
dose-response curves fit very well, giving half-max transduction constants (K) of 3700 versus 
1024 MOI units respectively for CD47-Lenti versus control Lenti.  Transduction of the human-
derived lung cancer epithelial line (A549) cell line showed that the CD47-Lenti can mediate high 
gene transfer (Fig. 2B).  Indeed, transgene expression efficiency in A549 cells was 3-fold greater 
for CD47-Lenti versus control Lenti, with respective half-max transduction constants (K) of 270 
versus 760 MOI units. Note that the control Lenti K’s for A549 cells and THP1 macrophages differ 
by only ~25% (760 versus 1024), consistent with standard Lentivirus being broadly infectious 
across cell types (Farley 2007).  
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Figure 2. CD47 inhibition of Macrophage Transduction & Enhancement of 
A549 Transduction 
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Figure 2. CD47 inhibition of Macrophage Transduction & Enhancement of A549 
Transduction. CD47 and Control-Lentis encode the reporter transgene RFP variant DsRed.MST 
under the control of a CMV promoter. Either control or CD47 displaying Lenti were added to cells 
in vitro at a vector to cell ratio (VCR) from 10 to 2000. Lentivectors were co-incubated with cells 
for 1 hour followed by washing. 72 hours later the percentage of transduced THP-1 macrophages 
(A) and A549 cancer epithelial cells (B) was determined by the RFP and Hoechst fluorescence 
quantitation. Both cell types showed a saturating response to VCR, and the transduction 
response was fit with Michaelis-Menten kinetics (K and m inset) (n≥3, p≤0.05, R2>0.95). 
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Mechanistic reasons for the transduction differences with CD47-Lenti were first explored by pre-
blocking SIRPA on both cell types. While SIRPA acts as an inhibitory receptor for uptake by 
macrophages, it is not reported to have such a function on other cell types such as lung epithelial 
cells perhaps because the downstream phosphatase SHP1 is relatively restricted to 
hematopoietic cells (Fig. 3A). In anticipation of in vivo studies below, primary NSG-derived 
splenic macrophages were used in lieu of the human macrophage THP-1 line, and we first 
confirmed that CD47-Lenti transduced NSG-macrophages about 3-fold less effectively than 
control Lenti at the same MOI (Fig 3B, left gray bar). Importantly, pre-blocking the NSG 
macrophages with anti-(mouse-SIRPA) (Fukunaga 2004) eliminated the difference in transduction 
between CD47-Lenti and control Lenti, which we plot simply as a ‘Transduction Ratio’ that 
becomes ~1 upon SIRPA blocking. Parallel experiments with the A549 cells used anti-(human-
SIRPA) and showed that the higher transduction of these epithelial cells by CD47-Lenti was 
eliminated by this function blocking antibody (Fig 3B, right red bar). The noted increase in 
transduction of A549 cells by CD47-Lenti versus Control-Lenti also depends on SIRPA, as an 
anti-SIRPA antibody decreases the Transduction Ratio to ~1 (Fig. 3B, right bars).  Thus with 
respect to CD47-Lenti interactions, SIRPA in these epithelial cells acts opposite to SIRPA in 
macrophages. 
 
CD47-SIRPA activation of the immuno-inhibitory phosphatase SHP-1 inactivates several proteins 
that make engulfment efficient, particularly nonmuscle Myosin-IIA motors that help pull targets in 
during phagocytosis by macrophages (Tsai 2008). The Myosin-II ATPase inhibitor blebbistatin 
should therefore inhibit uptake similar to the effect of displaying CD47 (Fig. 3A). THP-1 
macrophages were pre-treated for 1 hr with the Myosin II inhibitor blebbistatin (5-50 µM) and then 
control Lenti or CD47-Lenti were added. While the effect of blebbistatin on macrophage 
transduction by CD47-lenti was insignificant (Fig. 3C), which is consistent with redundant 
pathways, transduction by the control Lenti decreased with high blebbistatin to that of CD47-
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Lenti. The half-max inhibition constant of ~5 µM is also consistent with inhibition of the Myosin-IIA 
ATPase (Allingham 2005).  These results support the conclusions that Myosin-IIA is specifically 
involved in the efficient uptake of Lentis by macrophages and that CD47 reduces macrophage 
uptake of Lentis by inhibiting Myosin-IIA motor activity. Phagocytosis of IgG-opsonized red blood 
cells is also made efficient by Myosin-IIA that the CD47 on the red cell inhibits to suppress 
engulfment (Tsai 2008). The comparison begins to suggest that lentiviruses are strongly 
opsonized to drive clearance, perhaps with IgG, which is consistent with serum opsonization of 
lentivirus (Jolly 1989a, Jolly 1989b, DePolo 2000). 
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Figure 3. Mechanism of Inhibition & Enhancement 
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Figure 3. Mechanism of Inhibition & Enhancement.  (A) Lenti CD47 display is expected to 
inhibit uptake by macrophage via binding to SIRPa, which leads to activation of the SHP-1 
phosphatase that deactivates proteins involved in macrophage uptake including FcR mediated 
activation of Myosin-II motor. Myosin-II can also be inhibited by Blebbistatin. Epithelial derived 
A549 cells express SIRPA but, in contrast to macrophage, lack FcRs. Heatmaps quantify mRNA 
levels of relevant genes where black indicates minimum value and red the maximum value {(min, 
max): human THP-1 (2.4, 11.5), mouse spleen (5.2, 12.0), human A549 (1.9, 3.6)}. (B) Splenic 
macrophage and A549 cells were pre-treated with an anti-SIRPa IgG prior to transduction or not. 
The percentage of transduced cells was quantified by fluorescence microscopy detection of 
DsRed and Hoechst signals. The ratio of CD47-Lenti transduction to control lenti transduction 
was calculated for each condition. A ratio of 1 indicates equal transduction by the CD47- and 
control Lentis (n≥3, p≤0.05) (C) Macrophages were pre-treated with blebbistatin (5-50 µM) and 
then transduced with either control or CD47-Lenti (n≥3, p≤0.05). The control lenti macrophage 
transduction response to blebbistatin concentration fit well to a standard inhibition curve, (y= A+ 
B(K+X), R2>0.98), with A=6%, B = 225%µM, and, K =7.8 µM. (C, inset) A549 cells were pre-
treated with Blebbistatin for 1 hour prior to transduction with control lenti. A549 transduction 
shows no response to blebbistatin.   
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CD47-Lenti Enhances in vivo Circulation Unless SIRPA is Blocked 
To determine the impact of CD47 display on in vivo circulation of lentivirus, either a control or 
CD47-lenti were injected into the tail veins of NSG mice, and the blood was periodically sampled 
for a functional titer in HEK 293T cultures (Fig. 4A). Both control and CD47-Lenti were 
progressively cleared from the bloodstream, but the control-Lenti was cleared more rapidly so 
that the ratio (circulating CD47-lenti) / (Control-lenti) increased with time (Fig. 4B). At 10 min 
post-injection, this ratio favored CD47-lenti by just 3-fold, but by 45 min the advantage of CD47-
lenti increased to nearly 10-fold relative to control vectors. This ratio remains high up to 24 hrs, 
but decreasing titers add uncertainty to long-term measurements. Fitting just the initial 45 min of 
ratio data with an exponential not only provides a good fit but also yields a fitting constant T = 16 
min for the time at which CD47-displaying Lenti are 2-fold more abundant than control Lenti (Fig. 
S4A). This persistence ratio doubling time agrees well with the T ≈ 20 - 30 min obtained for the 
CD47-conferred advantages in circulation of highly opsonized mouse red cells and also highly 
opsonized opsonized nanobeads (Rodriguez 2013). Circulation results for unopsonized mouse 
and human red cells (Strowig 2011, Oldenborg 2000) yield in similar analyses T ~ 10 hrs (Fig. 
S4A), which means the advantage of CD47 is slow to manifest for unopsonized entities in 
circulation. The comparison again suggests that lentiviruses are strongly opsonized to drive 
clearance, consistent with serum opsonization of lentivirus (Jolly 1989a, Jolly 1989b, DePolo 
2000), while also indicating that CD47 delays opsonization-driven clearance in vivo. 
The lentivector titer in circulation 45 min after injection relative to that at 10 min defines for each 
mouse a viral kinetics ratio (VKR) that succinctly characterizes the effect of blocking in vivo with 
anti-mSIRPA.  Anti-mSIRPA blocks macrophage interactions with CD47 not only in vitro (Fig. 3B) 
but also in vivo where it binds NSG macrophages (Rodriguez 2013). Pre-injecting this antibody in 
NSG mice indeed decreases the VKR significantly for CD47-Lenti (Fig. 4C). CD47-Lenti’s 
antibody-blocked VKR is also statistically similar to that of control Lenti, which shows a VKR that 
is statistically independent of whether anti-mSIRPA is pre-injected or not. The enhanced in vivo 
circulation of CD47-Lenti is therefore due to a CD47-SIRPA interaction.  
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Figure 4. CD47 Enhances in Vivo Circulation 
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Figure 4. CD47 Enhances In Vivo Circulation. (A) CD47- or Control Lentis were injected via tail 
vein to NSG mice. A 10 min 45 min, and 24 hour orbital bleed were analyzed via functional titer 
for Lenti concentration.  (B) Either control or CD47 lenti (1x109) were injected via tail vein to NSG 
mice. The circulation ratio, the relative concentration of CD47-Lenti relative to control-Lenti, was 
quantified (n = 13, p≤0.05).  Both control and CD47-Lenti were cleared from the blood stream, 
with the control-lenti being cleared more rapidly (inset p≤0.05) and consistent with VKR (Fig. 4A). 
The circulation advantage ratio, R, is the ratio of CD47-Lenti to control Lenti, remaining in 
circulation as determined by a functional titer assay of blood samples. By 45 minutes post-
injection, CD47-Lentis are nearly 10-fold more abundant in circulation than control-Lenti (n=13 
p≤0.05). The time constant T is where R=2). The time constant, τ, for Lentivectors is τ=0.35h 
(blue).  (C) The Virus Kinetics Ratio (VKR), or the ratio of virus remaining in circulation at 45 
minutes relative to that remaining at 10 minutes, was quantified and gives a measure of the 
persistence in circulation of the lentivector. Further, SIRPA was blocked in vivo with an anti-
SIRPA mAb against mouse SIRPA, or not, prior to injection of lentivirus (n≥3, p≤0.05) 
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In vivo Transgene Expression: decreased in Macrophages, increased in Tumors 
CD47-inhibited clearance of cells has primarily been attributed to impeding uptake by splenic red 
pulp macrophages (Oldenborg 2000). Spleens of NSG mice here were therefore isolated 5 days 
after injection in order to allow ample time for expression of the transgene, and then the spleens 
were dissociated into single cell suspensions for identification of transduced macrophages 
(positive for F4/80, also known as Emr1).  Mice injected with CD47-Lenti showed nearly two-fold 
fewer DsRed+ splenic macrophages relative to mice injected with control Lenti (Fig. 5A). This 
seems quantitatively consistent with the 2-3 fold enhancement of circulating CD47-Lenti (Fig. 
4B,C).  
NSG mouse livers were also removed and sectioned, with confocal imaging of 
immunofluorescence showing F4/80+ cells with a reticulated morphology consistent with Kupffer 
cells (Fig. S5A) and also an abundance of mouse-CD47+ cells with round morphologies 
consistent with hepatocytes (Fig. S5B). Both control-Lenti and CD47-Lenti transduced Kupffer 
cells and hepatocytes (Fig. S5C, D), but quantitation indicated two-fold fewer DsRed+ Kupffer 
cells for CD47-Lenti (Fig. 5B). To our knowledge, CD47-inhibited clearance has not been 
reported for liver macrophages; but these cells do derive from bone marrow (Klein 2007), and 
phagocytosis of bone marrow macrophages is inhibited by the CD47 pathway (Oldenborg 2000). 
Expression profiles in the liver were therefore analyzed and provide evidence of Emr1-expressing 
cells with reasonably abundant SIRPA and SHP1 (Ptpn6) (Fig. S5E).  Moreover, in light of the 
similar two-fold decrease in Kupffer cell and splenic macrophage transduction with CD47-Lenti 
here, a similar inhibitory pathway seems likely. 
A more persistent circulation and reduced uptake by macrophages with the CD47-Lenti suggests 
that the greater abundance of these novel vectors in blood should better infect other accessible 
cells relative to control Lenti. Solid tumors tend to be leaky to many types of circulating particles 
(Dvorak 1988, O’Connor 1984), and so A549 xenografts in NSG mice were established and tail-
vein injected with the Lentis. As with the macrophage studies, 5 days was allowed for transgene 
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expression, and then the xenografted tumors were removed, disaggregated, and cells were 
analyzed by flow cytometry (Fig. S5F). The A549-identified population showed on average ~7-
fold more transgene-positive cells in mice injected with CD47-lenti versus control-Lenti (Fig. 5C). 
With the same xenograft model, CD47-nanobeads loaded with near-infrared dyes localized to the 
tumors 3-5-fold moreso than nanobeads without CD47 (Rodriguez 2013), and the result here is 
statistically similar. Only ~5% of A549 cells appeared transduced by CD47-lenti, but this seems 
reasonable because particles as large as lentiviruses (~100 nm) which leave the vasculature and 
enter tumors rarely permeate very deeply into tumors (Wong 2011). The CD47-Lenti results in 
vivo are nonetheless consistent with increased circulation, decreased uptake by macrophages, 
and increased delivery to other accessible cells.  
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Figure 5. CD47 inhibits DsRed expression by Macrophages and enhances DsRed 
expression in Human Tumor Cells  
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Figure 5. CD47 Reduces Transgene expression in Spleen and Liver Macrophage while 
Enhancing Transgene expression in Tumor Cells. (A). 1x109 CD47- or Control-Lenti were 
injected via tail-vein. 5 days post-injection spleens were mechanically dissociated. Splenic 
macrophage were identified by F4/80 immunostaining, and analyzed for RFP transgene 
expression by flow cytometry. CD47-Lenti injected spleens showed decreased splenic 
macrophage transduction (n=3, p=0.03). (B) 1x109 CD47- or Control-Lenti were injected via tail-
vein. 5 days post-injection livers were isolated. Tissue sections were analyzed by IHC and 
imaged for RFP expression by confocal microscopy. Cells that were consistent with Kupffer cell 
morphology (Fig S5A-D) and positive for RFP expression were quantified (n>6, p=0.003). (C) 
CD47- or Control-Lenti were injected via tail-vein to A549 xenograft-tumor bearing NSG mice, 
and 5 days post-injection tumors were isolated and analyzed for RFP transgene expression 
where CD47-lentivector mediated significantly higher transgene expression (n≥4, p< 0.05).  
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Discussion 
	  
Attachment of recombinant human-CD47’s immunoglobulin domain to polystyrene nano-beads 
that were IgG-opsonized was found in our recent studies to be sufficient to repress macrophage 
uptake in vitro and in vivo (Rodriguez 2013).  However, lentiviruses are far more complex than 
polystyrene beads. The HIV-1 derived vector (Dull 1998) has an inner core composed of three 
key structural proteins matrix, nucleocapsid, capsid (p24), with the latter assembling as hexamers 
and pentamers into a ‘fullerene cone’ lattice (Zhao 2013). Since the lipid-based envelope derives 
from host cells, current methods of enhancing delivery of lentiviral vectors have rightly focused on 
display of envelope proteins that can enhance uptake (Yang 2008, Padmashali 2011, Hwang 
2013, Bischof 2010) and gene expression within specific target cells (Follenzi 2004).  
Biodistribution studies show that lentiviruses are nonetheless taken up into macrophage rich 
tissues (Pan 2000) with gene expression preferentially found in macrophages (Van til 2004). 
Such uptake could in principle promote inflammation and challenge long-term transgene 
expression that is sought for treatment of genetic disorders.  
 
Molecular mechanisms of macrophage uptake of viruses are likely to be diverse and of course 
distinct for these professional phagocytes from virus internalization processes in other cell types. 
Antibody dependent enhancement of HIV infection has been demonstrated in vitro (Joualt 1989, 
Jolly 1989, Takeda 1990), and Fab’2 fragments that lack the Fc domain of intact antibodies are 
insufficient to enhance uptake while blocking Fc receptors does inhibit infection (Takeda 1990). 
Relevant studies of VSV-G pseudoptyped lentiviral vectors have shown in naïve serum that there 
are pre-existing IgGs that neutralize virus (DePolo 2000, Thiry 1978, Beebe 1981), and fetal 
bovine serum that is commonly used in lentiviral vector preparations can also contain virus-
specific IgGs (Offit 1984). Immunoblotting analyses of serum from pre-injected and vector-
injected mice likewise indicate that mice have pre-existing antibody that increases with time post-
injection (Baeklandt 2003). Importantly, both liver and spleen macrophages express FcγR 
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receptors that bind IgG, and both liver and spleen uptake of red cells is also clearly enhanced by 
IgG opsonization on red cells (Loegering 1989). Intravital imaging of liver further shows the FcγR 
dependent uptake of IgG opsonized cells into Kupffer cells (F4/80+, Cd11bhi) (Montalvao 2013). 
Likewise in spleen, red pulp and marginal zone macrophages express functional FcγR, as 
detected by IgG binding (Denham 1990). Splenic macrophages as well as bone marrow derived 
macrophages are clearly inhibited by CD47 displayed on cell membranes (Oldenborg 2000, 2001, 
Gardai 2005, Tsai 2008), and the findings here (Fig. 5A,B) suggest that Lentis which bud through 
cell membranes rich in hCD47 also have the ability to inhibit uptake by liver as well as spleen 
macrophages.   
 
CD47 is expressed on all cell types, including leukocytes (Brown 2001) that are HIV-susceptible. 
HIV particles that bud from such cells might therefore display some CD47 on their envelope and 
thereby impact infection.  Although results here suggest that HEK producer cells would normally 
need to overexpress CD47 (Fig. 1), while leukocyte progenitors can increase their CD47 levels in 
a manner that is correlated with internal tandem duplications of the receptor tyrosine kinase, 
CD135 (Majeti 2009). Moreover, a poxvirus encodes what has been claimed to be a CD47 
ortholog that causes a more severe pathology than virus lacking the protein (Cameron 2005), 
although claims of relevance to CD47 remain controversial (Hatherley 2006). Decreased 
macrophage uptake has the potential to reduce immune responses downstream of myeloid cell 
uptake of Lentis (Brown 2007, Rossetti 2011), and CD47 seems to modulate inflammatory 
response and induction of adaptive immunity (Demeure 2000, Latour 2001, Baba JEM 2013, 
Tseng 2013). While phagosome processing can affect the extent of antigen presentation (Blander 
2006), any effect of CD47 on antigen processing and presentation remains unclear.  
 
CD47-Lentis as generated here from an overexpressing HEK line appears effective in enhancing 
gene delivery via reduced macrophage uptake and increased circulation. CD47-Lentis may 
therefore be useful for gene therapy in this receptor-specific ‘anti-targeting’ approach. We find 
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that CD47 is comparable in abundance on the Lenti surface (7-75 molecules) to gp120 on 
physiological HIV-1 virions (7-70 molecules) as estimated by EM and biochemical studies 
(Bachrach 2005). The density of both Env and CD47, here on the novel vector, are lower than 
that reported for VSV-G on wild-type VSV (~600 molecules/um2 ) (Bunocore 2002, Cureton 
2010). CD47 display may be beneficially combined with receptor-specific targeting to diseased 
cells. Our findings might be relevant to understanding the pathology of some enveloped viruses 
such as HIV-1 that are recalcitrant to vaccine development. While past studies of CD47 have 
largely focused on interactions involving animal cells much larger than virus, findings here 
deepen the current understanding of macrophage uptake processes and CD47-SIRPA inhibition 
at a very small scale.  
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Supplementary Materials and Methods 
 
Materials Cells were washed with PBS without Ca2+ or Mg2+ (Invitrogen). For cell culture, 
RPMI-1640, DMEM, F12 medium, Penicillin-streptomycin, FBS, trypsin EDTA, and acridine 
orange were all purchased from Invitrogen. (±)-Blebbistatin was obtained from EMD Biosciences. 
 
Antibodies Primary antibodies used for flow cytometry, western blotting, and 
immunofluorescence include anti-human CD47 (B6H12, BD Biosciences), anti-mouse CD47 
(MIAP301, BD Biosciences), anti-GFP (Ab290, Abcam), anti-GST (Invitrogen), anti-mouse SIRPA 
(P84, BD Biosciences), anti-human SIRPA (SE7C2, BD Biosciences), anti-F4/80 (AbD Serotec). 
Secondary antibodies include donkey anti-mouse AlexaFluor 647 (Invitrogen), donkey anti-
mouse-PE (Sigma), donkey anti-rabbit AlexaFluor 488 (Invitrogen), anti-rat-FITC (Sigma), anti-
rabbit HRP-conjugated IgG (GE Healthcare).  
 
Cell Culture HEK 293T, A549, and THP-1 cells (ATCC) were respectively maintained in DMEM 
(high glucose, phenol red-), F12, and RPMI-1640 media. THP-1 cells were maintained in RPMI-
1640 supplemented with FBS and antibiotics. All media were supplemented with FBS and 1% 
antibiotics. THP-1 cells were differentiated in maintenance medium supplemented with 100 ng/mL 
phorbol myristate acetate (PMA) (Sigma) for two days and differentiation was confirmed by 
adherence to a solid substrate (cell culture plastic or glass).  
 
Plasmids The Δ8.91 lentivector plasmid, VSV-G envelope plasmid under control of a CMV 
promoter, and lentiviral transfer plasmids containing human-CD47-EGFP, and DsRed.MST under 
the control of a CMV promoter were kindly provided by Dr. Philip Zoltick. 
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Lentivector Transfection and Concentration. Lentis were generated by transient transfection 
of Control HEK 293T or HEK-CD47 293T cells with the packaging, envelope, and transfer 
plasmids with transfection reagent (Mirus). At 1 and 2 days post transfection, viral supernatants 
were collected and stored at 4*C. Combined supernatants were filtered through a 0.45 µm sterile 
filter, then pelleted at 25,000 RPM on SW32 rotor for 1.5-2 hours. Pellets were resuspended in 
100 µL PBS and stored at -80*C until use. Lentivector titer (LV/mL) was determined either by a 
functional titer assay or by p24 antigen ELISA (Center for AIDS Research, The University of 
Pennsylvania, Philadelphia, PA, USA). 
 
Equilibrium Sedimentation of Lentiviral Vector Supernatants Concentrated lentivector 
supernatants were overlayed on to a continuous sucrose gradient (20-60%), ultracentrifuged at 
50,000g for 18 hrs, and layers were carefully collected top to bottom by micropipette.  
 
Widefield Fluorescence Microscopy Images were acquired with an inverted microscope 
(IX71; Olympus) with a 60x (oil, 1.4NA) objective using a Cascade CCD camera (Photometrics). 
Image acquisition was performed with Image Pro software (Media Cybernetics Inc.). 
 
Sample Preparation for TIRF AFM Glass coverslips were cleaned with KOH followed by rinsing 
with sterile H2O and drying. Where indicated cleaned coverslips were further coated with 
antibody (1:1000 to 1:100 dilution in PBS) for ≥ 1hr then rinsed by gentle submersion in PBS. 
Lentivector samples were incubated with coverslips for up to 1hr at room temperature then rinsed 
by gentle submersion in PBS.  
 
Coupled Total Internal Reflection/ Atomic Force Microscopy Images were acquired with an 
inverted microscope (Nikon Eclipse) with a 100x (oil, 1.4NA) objective using a Cascade II 
EMCCD camera with liquid cooling. Samples were illuminated with Blue (Coherent Sapphire, 488 
nm, 75 mW), and/or Green (Crystalaser CL, 532 nm, 100 mW) lasers. The angle of the laser 
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beam was adjusted to maximize GFP signal relative to background signal. A Veeco AFM was 
mounted on top of the inverted microscope and imaging was performed in tapping mode on areas 
of sample that were confirmed via TIRFM to contain GFP-positive particles. 
 
Functional Titer of Lentiviral Stocks  HEK 293T cells were plated at 1.2x105 cells/well in 12 
well cell culture dishes (3.8 cm2). 24 hours post cell plating, serial dilutions of lentiviral vector 
stocks were prepared and added to HEK293T cells pre-treated with DMEM supplemented with 
Polybrene (5ug/mL) (Sigma) for 1 hour. Exactly 72 hours post addition of lenti, DsRed+ cells were 
quantified by fluorescence microscopy. The concentration of functional lentiviral vector stocks 
was determined from the number of RFP+ HEK cells obtained from a given volume of lentiviral 
vector stock. 
 
Flow Cytometry of HEK Producer Cells and hRBC Cells were briefly trypsinized and quenched 
with DMEM supplemented with 10% FBS followed by immunostaining and analysis of B6H12-PE 
and GFP fluorescence with a BD FACS Calibur.  
 
Immunofluorescence Analysis of HEK-CD47-GFP HEK 293T cells were cultured on LabTek 
culture dishes, fixed with 3.6% Formaldehyde, and immunostained with anti-human CD47, 
followed by anti-mouse-IgG-AlexaFluor 647 secondary antibody, and Hoechst 3342.  
 
Western Blotting Cells and lentivector supernatants were lysed with RIPA buffer 
supplemented with a mammalian protease inhibitor cocktail (Sigma). The lysate protein 
concentration was analyzed by a BCA assay (Pierce). Equal masses of whole lysates were 
separated on 4-12% Bis/Tris SDS-PAGE gels (Invitrogen) then protein was transferred to a 
polyvinylidene fluoride (PVDF) membrane with iBlot Gel Transfer Device (Invitrogen), followed by 
blocking with 5% nonfat dry milk solution for one hour. Incubation with primary antibody was done 
at 4*C overnight, washed 3x with TTBS. These were then incubated with secondary anti-Rabbit 
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HRP for 1-3 hours at room temperature. The HRP substrate, Chromosensor TMB substrate 
(Genscript), was applied for 5 min, followed by washing 3x with TTBS. Blot Images were 
analyzed with ImageJ. 
 
Ex Vivo Spleen Culture Spleens were isolated from NSG mice, mechanically dissociated and 
treated with 1 mL Red Blood Cell Lysis buffer (Sigma) for 1 minute at room temperature. The cell 
mixture was then diluted in 20 mL RPMI-1640, centrifuged for 300 x g for 5 minutes, cells were 
further washed with RPMI-1640 >3 times. Cells were then plated at 300 µL of a 1E7 cells/mL 
suspension to each chamber of an 8-chambered glass-bottomed dish (Nunc Lab Tek dishes) in 
RPMI-1640. 24 hours post-plating cells were washed 3x to remove nonadherent cells. Adherent 
cells were immunostained with anti-F4/80 to confirm F4/80 expression of adherent cells. 
 
Tumor Xenografts and Flow Cytometry Analysis of Dissociated Tumors 1x106 A549 cells 
were suspended in Matrigel and injected to each flank of NSG mouse. 5 weeks post A549 
injection mice were injected via tail vein with 3 x 108 Lentivectors.  Tumors were isolated and 
minced with dissection scissors. Dissociated tissue was transferred to trypsin, incubated for 3 
minutes, followed by quenching with 2% FBS/PBS. Dissociated cells were pelleted, and 
resuspended in warm Dispase (5 mg/mL Stem Cell Technologies) supplemented with 
Collagenase I (Sigma, 3 mg/mL) and DNAase (Calbiochem, 1mg/mL). 
 
Immunohistochemistry of Tissue Sections Organs were soaked in 4% formaldehyde for 4 
hours at 4*C then transferred to 4% FA, 20% sucrose in PBS for 48-72h. Tissue was cut into 2-5 
mm cubes and transferred to OCT and snap frozen. OCT blocks were sectioned by microtome, 
rinsed with PBS, blocked with 10% FBS/PBS, stained with primary and secondary antibodies in 
10% FBS/PBS.  Sections were extensively rinsed between steps by submerging in PBS.  
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Supplementary Figures 
 
Figure S1. Quantification of CD47 on HEK Producer Cells
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Figure S1. Quantification of CD47 on HEK Producer Cells. (A) CD47 display by HEK and 
HEK-CD47-GFP producer cells and human RBCs was quantified by anti-CD47 detection via flow 
cytometry. (B) Lysates of HEK-CD47, a similarly engineered HEK-murineCD47 cell line, and 
hCD47-Lenti were separated by SDS_PAGE gel, and proteins within 50<MW<60 were isolated 
and analyzed by Mass-Spectrometry for CD47-derived peptides. (C) The density of CD47 was 
estimated on each cell type, by determining the number of CD47 molecules per cell by correlation 
with the anti-CD47 fluorescence geomean of RBC which are reported to display ~25,000 
molecules of CD47 (Mouro-Chanteloup 2003). The density on the cell surface was estimated by 
taking the ratio of the calculated number of CD47 molecules and the reported surface area of 
HEK cells of 2591 um2 (Sommerhage 2008) or RBCs of 140 um2 (Hategan 2003).  
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Figure S2. TIRF Microscopy and AFM of CD47-GFP Displaying Lentivirus
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Figure S2. TIRF Microscopy and AFM of CD47-GFP Displaying Lentivirus. (A) Lentivirus 
supernatants were incubated with clean uncoated-glass coverslips and then imaged via TIRF 
microscopy for CD47-GFP intensity. (B) The GFP intensity for individual particles in whole 
lentivector supernatants was quantified. (C) The GFP intensity for individual particles in layers 13 
and 14 of a sucrose gradient purified supernatants was quantified (Fig S3). (D) AFM imaging in 
tapping mode reveals pleomorphic quasi-spherical lentivectors. 3D pseudo-image of height (left) 
and cantilever amplitude (right). (E) The height of the lentiviral particles has a bimodal 
distribution, with the data fitting to a double Gaussian and fitting parameters A, µ, and σ are inset. 
(F) Lentiviral vectors were exposed to the TIRFM blue laser (~480 nm) for at least 2 minutes, and 
the change in CD47-GFP intensity of particulates was quantified. 
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Figure S3. Immunoblotting of Sedimentation-Equilibrium Purified CD47-Lenti 
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Figure S3. Immunoblotting of Sedimentation-Equilibrium Purified CD47-Lenti.  CD47-Lenti 
supernatants were purified over a continuous sucrose density gradient, and then carefully 
aspirated top to bottom with a high-gauge needle into 20 x 50 µL aliquots. (A) Particles are 
expected to travel through the gradient until reaching an isopycnic region. Capsid containing 
Lentis should migrate farther through the gradient than less dense cellular vesicles. Each of the 
20 layers was analyzed for (B, C) functional titer, (D) Coomassie stain for total protein, and (E) 
western blotting for GFP. The anti-GFP immunoblot indicated a 60 kDa band that is consistent 
with the CD47-GFP fusion protein. (F) Densitometry of the coomassie and western blot was 
performed. (G) p24 ELISA and functional titer measurements are compared for unconcentrated, 
sucrose gradient purified, and concentrated lentiviral vector preparations. P24 is related to 
functional titer  by y=a*x^k with a=0.01 pg/LV and k=1 (R2=0.99).  
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Figure S4. In Vivo Circulation Analyses and Quantitative Analysis of Published Data
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Figure S4. In Vivo Circulation Analyses and Quantitative Analysis of Published Data. (A) 
Schematic of functional titer of in vivo blood samples that was used to quantify lentiviral vectors 
remaining in circulation. (B) The circulation ratio is plotted for in vivo dosage from 3x108 
LV/mouse to 10x108 LV/mouse. (C) The time constant, T, is equal to the product of ln(2) and tau.  
The time constant for Lentivectors is T=0.15h (blue). The time constants for other relevant 
particles are as follows: opsonized muRBC T= 0.26 h (Rodriguez 2013, grey), opsonized 
polystyrene nanoparticles T = 0.27 h (Rodriguez 2013, light blue), unopsonized hRBC in NSG 
mouse versus unopsonized muRBC in SIRPA-/- mouse T= 29h (Strowig 2011, pink) and 
unopsonized muRBC in C57BL/8 mice T=8h (Oldenborg 2000, red) and are plotted for reference.  
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Figure S5. Immunohistochemistry and Flow cytometric analyses of Liver and Xenograft 
Tumors
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Figure S5. Immunohistochemistry and flow cytometric analyses of liver and xenograft 
tumors. NSG mice were injected via tail vein with either a control or CD47-Lenti (1x109). Mice 
were sacrificed and in vivo perfused with PBS and 4% formaldehyde. Livers were isolated and 
incubated in a formaldehyde-sucrose solution for 48 hours prior to cryosectioning and 
immunostaining for (A) anti-F4/80 and (C) anti-mouse CD47. Liver sections were immunostained 
for RFP and imaged by confocal microscopy (B & D). (E) Microarray data indicate the 
transcription of key genes within spleen, liver, and muscle tissues of man and mouse; these are 
compared by heatmap analysis. As shown in color bars below maps, green indicates low and red 
high gene transcription. (F) Liver sections were immunostained for mSIRPA and nuclei were 
identified by Hoechst staining (i). A F4/80 immunostain colocalized with mSIRPA expression (ii). 
(G) TdTomato A549 tumors were isolated, dissociated and analyzed for TdTomato Fluorescence 
and forward and side light scatter. Forward and side scatter contour plots identify two distinct 
populations (G, Inset), P1 and P2. The forward-scatter and Tdtomato fluorescence was 
quantified for each population. Error bars indicate ±1SD (blue) and ±3 SD (pink) (n=3, p≤ 0.01. 
(G) A549 tumors were isolated and dissociated into single cell suspension for analyzed by flow 
cytometry for anti-mSIRPA.  
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CHAPTER 4: DISCUSSION AND FUTURE DIRECTION	  
 
The goal of this work was to improve our understanding of CD47’s role in regulating phagocytosis 
in an effort to fill critical gaps in two distinct clinically relevant fields of research: aged red blood 
cell clearance and lentiviral vector mediated gene therapy.  
 
(1) Phagocytic Clearance of Rigid Red Blood Cells  
	  
In the RBC field, it was known that phagocytosis of viable IgG opsonized cells can be inhibited by 
CD47 display, but not known how rigidification, as occurs in cell aging, affects CD47’s ability to 
inhibit uptake. The work here shows that rigidification of red cells overrides CD47 by 
hyperactivating myosin IIA at the phagocytic synapse. Fluorescence imaging of the phagocytic 
synapse revealed that at the synapse with rigid cells, macrophages had accumulated significantly 
higher levels of myosin-IIA. Further rigidification correlated with enhanced phagocytosis, and no 
effective result of a CD47 blocking antibody on phagocytosis. Previous studies showed red pulp 
splenic macrophage to be sensitive to CD47 display, showing a significant increase engulfment of 
RBCs derived form a CD47 knockout mouse (CD47 -/-) relative to control RBCs (CD47 +/+) 
(Oldenborg 2000). Work here indicates that blocking CD47 has no effect on splenic macrophage 
engulfment of rigidified cells, suggesting that rigidification effectively overrides CD47 inhibition of 
engulfment in vivo.  
 
Work from our lab has previously identified Myosin-II as a downstream target of CD47-SIRPa 
signaling (Tsai 2008), and separately studied the broad roles of matrix rigidity in regulation of the 
cytoskeleton in cellular functions such as adhesion.  Here, Substrate rigidity was found to 
enhance activation of Myosin-II in mesenchymal and hematopoietic stem cells (Rehfeldt 2012, 
Shin 2014).  These two lines of study intersect in this work that examines the effect of target cell 
rigidity on myosin accumulation at the phagocytic synapse, and how this affects CD47 inhibition 
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of myosin-II accumulation. Macrophage phagocytosis has previously been proven to be 
mechanosensitive, with macrophages being more efficient in the engulfment of rigid cells 
(Beningo 2002). Where rigidity enhances myosin II accumulation at the synapse, CD47 
decreases myosin II accumulation at the synapse. As a result CD47 inhibition is less efficient in 
the phagocytosis of rigid cells. We expand our understanding of CD47 as a marker of self that 
prevents phagocytosis of viable of cells, into understanding how the effects of CD47 may be 
modulated as cells age. Cellular rigidity is reported to increase with age (Mohandas 2008), and 
we find here that rigidification overrides the self-signal allowing cells that have sufficiently aged to 
be efficiently engulfed by macrophage. This was not previously known and this work helps us 
better understand the role of rigidity in CD47 signaling. We now know that among the changes 
that occur with erythrocyte aging, rigidity itself does play a role in affecting CD47’s real but limited 
ability to signal self. Thus, the ability of cellular rigidity to override CD47 signaling offers insight 
into how aged and rigidified self-cells that still express high levels of CD47 can become cleared 
as needed.  
 
While this work offers novel insight into how aged cells are cleared, there are other biophysical 
and biochemical factors besides stiffness that can be considered to affect CD47 inhibition. 
Changes in biophysical properties, cell rigidity and shape, was the focus of this thesis work, but 
increased IgG deposition on aged cells may be an additional complementary factor that 
enhanced uptake of rigid aged cells. Furthermore, aldehydes are produced as a result of 
oxidation (Barelli 2008), and can cross-link amino groups. Analyses of the membrane of the 
proteome of stored red cells that are exposed to oxidative stress have demonstrated dramatic 
alteration and cleavage of several RBC proteins including integral membrane protein, Band 3  
(D’Amici 2007). Cross-linking of erythrocyte Band 3 has been shown to lead to IgG-opsonization 
and subsequently complement deposition (Franco 2013) that allows macrophages to recognize 
and clear these aged-erythrocytes (Kay 1975).  
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Previous work from our lab found that display of recombinant CD47 prolongs in vivo circulation 
and targeted delivery of polystyrene nanoparticles (Rodriguez 2013). Similarly, CD47 mediated 
inhibition was also observed in macrophage engulfment of polystyrene microparticles that are 
similar in size to erythrocytes (Tsai 2008).  Polystyrene is significantly more rigid than 
erythrocytes. A previous study indicated that macrophage phagocytosis of synthetic particles is 
mechanosensitive, and the results from this thesis work that indicate that CD47 signaling is 
overridden with rigid erythrocytes. Thus CD47 inhibition of uptake of rigid polystyrene particles 
could be expected to be limited as well. However, it is clear that CD47 densities comparable, or 
even less than, those found on healthy erythrocytes is sufficient to inhibit uptake of these rigid 
spheres. While the polystyrene particles are more rigid than erythrocytes, they are also spherical 
in contrast to rigid erythrocytes that have a non-deformable discoid shape. To understand how 
this difference in shape could affect the ability of CD47 to functionally signal self on rigid spheres, 
we also studied the effect of CD47-inhibition of engulfment of hypotonically rounded erythrocytes. 
Rounding the erythrocyte rescued some of CD47’s ability to signal self, indicating that not only 
rigidity, but also shape can regulates CD47 inhibition. 
 
 
(2) The Novel CD47-Lenti Provides Increased Therapeutic Potential 
 
In vivo delivered lentivectors are efficiently cleared by macrophage, with the majority of the 
delivered transgene found in the macrophage-rich spleen and liver (Pan 2002). Within the liver 
the majority of the delivered gene is expressed in resident liver macrophage (van Til 2004). 
Macrophage clearance has thus been a roadblock to the development of the therapeutic. The 
work here shows that a novel lentiviral vector that displays CD47 on the envelope shows reduced 
macrophage transduction, which correlates with enhanced gene delivery to xenograft tumors.  
CD47 offers the potential to limit clearance by macrophages in a fashion that complements 
current targeting techniques. Importantly, the engineering of the novel CD47 over-expressing 
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HEK 293T producer cell will allow this technique can be readily implemented with minimal 
perturbation to current transfection protocols. 
 
Lentiviral vectors are mainly cleared and engulfed by resident tissue macrophage in the liver and 
spleen. This makes therapy inefficient and may contribute to inflammation that further reduces 
therapeutic potential. Engineering vectors to display proteins with high affinity for a targeted cell 
type has been one technique already developed to enhance delivery. However macrophages are 
ubiquitous and specialized in clearance of small particles, so that it is likely that a lentivector, 
even one engineered with a targeted envelope protein, may be engulfed by a macrophage before 
reaching the target cell. CD47 on the surface of the vector can bind to SIRPA and trigger 
downstream inhibition of the myosin-II motor. Macrophage uptake has been shown to be FcR and 
IgG dependent, and this type of uptake mechanism is known to be inhibited by CD47-SIRPA 
signaling. Thus CD47 is an efficient anti-targeting mechanism in which presentation of the CD47 
molecule allows the lenti to escape macrophage in the spleen and the liver, and potentially other 
resident tissue macrophage, that are sensitive to CD47 inhibition.  
 
Thus CD47 display was found to inhibit macrophage uptake or lentiviral vectors in vivo in a 
manner that is dependent on SIRPA. This extends the current understanding of CD47 ability to 
act as a ‘marker of self’ on the surface of mammalian cells and synthetic particles towards 
understanding the potential for human pathogens, such as the lentivirus, to utilize the ‘marker of 
self’ to avoid macrophage clearance. This perhaps has implications for viral infection.  HIV-1 
infects macrophage, where IgG opsonization and display of a functional Fc receptor increases 
macrophage infection (Takeda 1990). This suggests that IgG can enhance uptake into 
macrophage in a manner that does not necessarily lead to destruction of the virus. Phagocytic 
clearance of a pathogen can affect the macrophage’s inflammatory state and lyososomal 
maturation (Janeway 2005). The implications of CD47 display for inflammation and antigen 
processing are beginning to be understood (Baba 2013, Tseng 2013). An enveloped poxvirus 
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(Family, Poxviridae, Genus Leporipoxvirus) is reported to encode a CD47 homologue (Cameron 
2005), and enhances the pathogenicity of the virus, potentially because reduced uptake into 
macrophage reduces the host’s ability to mount a sufficient immune response. Based on the 
results here with CD47 displaying lentiviral vectors, it seems reasonable to hypothesize that 
CD47-SIRPA interactions can affect pathogenicity of an enveloped virus such as HIV-1, that 
typically buds from leukocytes that are known to display CD47 (Brown 2001).  
 
(3) Future Direction 
 
Taken together the work here underscores contributions of biophysical properties of cellular 
targets to CD47 inhibition. Specifically, the rigidity and shape of phagocytic targets were identified 
here to affect CD47’s ability to signal self and thus inhibit macrophage phagocytosis. Importantly, 
the work highlights a novel, powerful, and simple method of improving lentiviral vector mediated 
gene therapy, a promising therapeutic treatment. The next steps would be to apply both of these 
findings towards the improvement of current therapies. A proposed therapeutic to enhance anti-
cancer gene therapy, that is based on the novel findings of this work, is discussed in more detail 
below. 
 
The current work with lentiviral vectors showed that reduced macrophage uptake correlated with 
enhanced delivery to a xenograft tumor. The work utilized CD47-Lenti that encoded an RFP 
reporter gene that allowed for efficient detection of transduced cells. Expanding on this work, it 
would be useful to look at delivery of a transgene that limits growth and enhances cytotoxicity for 
cancer cells.  It is expected, that CD47-Lenti display will enhance circulation and tumor delivery in 
a manner that is independent of the encoding transgene such that transgenes with therapeutic 
efficacy can be better delivered via the CD47-Lenti as compared to a Control Lenti.   
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CD47 is expressed on all cells, and so there are broader implications of its functions beyond its 
role in erythrocytes. CD47 was initially identified as a surface protein that was over-expressed on 
breast cancer (Campbell 1992).  Much of the recent work on the role of CD47 in cancer has 
shown that CD47 overexpression in various types of tumors allows the cancerous cells to avoid 
macrophage clearance (Majeti 2009). This suggests that cancer cells have overtaken CD47 
signaling to promote their growth. Thus there is great interest in CD47 as an anti-cancer target. 
Current efforts to combat CD47 expression have focused on small molecule therapeutics that 
block CD47 as well as siRNAs that downregulate CD47 expression.  The work here with rigid red 
blood cells highlights that cellular rigidification is another route to overcome CD47 inhibition. 
Rigidification may inhibit CD47 signaling in tumor cells, and thus enhance their clearance in vivo.  
When leukemia is exposed to therapeutic agents such as daunorubicin, the cellular rigidity 
increases two-fold and leads to increased physical entrapment in the vasculature (Lam 2007). 
The effect that this rigidification has on macrophage clearance, and particularly on CD47 
inhibition of macrophage phagocytosis of leukemia, remains to be determined. 
 
 As demonstrated here for controllably rigidified erythrocytes, the increased rigidity of 
chemotherapy-treated cancer cells may contribute to enhanced macrophage clearance by 
increasing myosin-II activation in a manner that overrides CD47 ‘self’ signaling. As identified in 
this work, targeted rigidification may be a complementary method to counter CD47-signaling.  
Aldehyde rigidification occurs also in the course of normal ageing. The most aggressive cancers 
may be able to subvert this rigidification mechanism, potentially enhancing their ability to persist. 
ALDHs are a group of enzymes that are reported to deactivate physiological aldehydes. Aldehyde 
dehydrogenase (ALDH) is overexpressed in certain aggressive forms of cancer (Ginestier 2007). 
Aldehydes are capable of covalently cross-linking amino groups, and in vivo aldehyde treatments 
lead to cellular rigidification. Thus ALDH may allow cells, and especially cancer cells that over-
express the enzyme, to escape this rigidification process. Although shRNA, RNAi, and small 
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molecule treatments against ALDH have been explored in cancer cells (Raha 2014), and found to 
mediate cytotoxicity, their effects on CD47 inhibition remain to be determined.	  
The conclusions from the two main branches of this thesis, considered together, suggest that (1) 
CD47 on vector surfaces can reduce phagocytic clearance and thereby enhance delivery to 
target cells, including tumors, and (2) that rigidification is a means to override CD47 signaling. 
Rigidification as a means for counteracting CD47 inhibition may have therapeutic efficacy in 
overcoming CD47 overexpression and avoidance of immunosurveilance in cancer.  For instance, 
an important contribution to the existing literature may come from determining whether or not the 
CD47-Lenti can mediate a therapeutic effect on cancer cells, via delivery of an ALDH shRNA, 
with the goal of cancer cell rigidification in an effort to diminish CD47 inhibition of immune 
clearance of cancer cells.  
 
The results here indicate that CD47 display by lentiviral vector can increase circulation of lentiviral 
vectors, and increase vector delivery to xenograft tumors. CD47-display, may be enhanced by 
currently utilized targeting mechanisms, including the display of cancer specific receptors under 
control of a cancer specific promoter (Pariente 2007). Lenti CD47-display is complementary to 
already developed targeting mechanisms such as pseudotyping and promoter engineering. While 
these methods enhance delivery to a target cell, CD47 avoids clearance by macrophage and thus 
the combination is expected to be synergistic, making lentiviral gene therapy even more effective. 
While studies have shown that ALDH inhibition is effective anti-cancer target, as ALDH 
counteracts negative effects of reactive oxygen species (Raha 2014), whether delivery of an 
ALDH shRNA, by a CD47-displaying lentivector has increased efficacy remains to be determined. 
Further whether or not ALDH silencing results in increased rigidification in a manner that may 
counteract CD47 inhibition also remains to be examined. Thus the two arms of this thesis identify 
potential improvement to existing therapies. First, rigidification may be a parameter that can be 
manipulated in order to overcome CD47 overexpression in cancer cells. Second, CD47 display by 
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lentiviral vectors can increase circulation and thus delivery to target tissues of lentiviral gene 
therapy vectors. 
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